@prefix : <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix core: <http://purl.obolibrary.org/obo/uberon/core#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix pato: <http://purl.obolibrary.org/obo/pato#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix time: <http://www.w3.org/2006/time#> .
@prefix core1: <http://purl.obolibrary.org/obo/core#> .
@prefix terms: <http://purl.org/dc/terms/> .
@prefix uberon: <http://purl.obolibrary.org/obo/uberon#> .
@prefix subsets: <http://purl.obolibrary.org/obo/ro/subsets#> .
@prefix oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix OpenPVSignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl#> .
@base <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function> .

<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function> rdf:type owl:Ontology ;
                                                                                     owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                                 mp: ;
                                                                                     rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/255494"^^xsd:anyURI ;
                                                                                     rdfs:label "Levetiracetam and impaired renal function"^^xsd:Literal ;
                                                                                     owl:versionInfo "draft-v0.95-20211025"@en .

#################################################################
#    Annotation properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code
OpenPVSignal:has_ATC_code rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code
OpenPVSignal:has_ICD_code rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code
OpenPVSignal:has_MedDRA_code rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term
OpenPVSignal:has_MedDRA_prefered_term rdf:type owl:AnnotationProperty .


#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
OpenPVSignal:Free_text_reporting_element rdf:type owl:ObjectProperty .


###  http://purl.org/mp/publishedBy
mp:publishedBy rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


#################################################################
#    Data properties
#################################################################

###  http://purl.org/mp/citation
mp:citation rdf:type owl:DatatypeProperty .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionARF_and_drugs
:ARF_and_drugs rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Warning_Information ;
               OpenPVSignal:refers_to_adverse_effect :acuteRenalFailure ;
               OpenPVSignal:refers_to_drug :acetaminophen ,
                                           :aminoglycosides ,
                                           :cisplatin ,
                                           :lithium ,
                                           :vancomycin ;
               OpenPVSignal:has_content "Examples of nephrotoxic medicines that are known to cause ARF are aminoglycosides,acetaminophen, cisplatin, lithium, and vancomycin." ;
               rdfs:label "ARF and drugs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionAcute_renal_failure_pathophysiology
:Acute_renal_failure_pathophysiology rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Free_text_reporting_element ;
                                     OpenPVSignal:refers_to_adverse_effect :acuteRenalFailure ;
                                     mp:references :Ref.2 ;
                                     OpenPVSignal:has_content "Acute renal failure (ARF) is a life-threatening condition. Renal insufficiency is impairment of renal function that is less severe. ARF can be classified as: prerenal ARF with diminishing circulating arterial volume caused by conditions such as dehydration, sepsis and cardiac failure; or intrinsic renal ARF with renal parenchymal damage resulting from glomerulonephritis, rhabdomyolysis, acute interstitial nephritis; or postrenal ARF with obstruction to the urinary tract from for example tumors or posterior urethral valves. Medicines can negatively affect the renal function directly by reducing the blood flow, or indirectly by inducing for example allergic reactions to the renal tissues. Examples of nephrotoxic medicines that are known to cause ARF are aminoglycosides, acetaminophen, cisplatin, lithium, and vancomycin. Medicines known to induce interstitial nephritis are antimicrobials (e.g. cephalosporins, penicillins and sulphonamides), NSAIDs, diuretics and certain anticonvulsants (carbamazepine, phenytoin). Topiramate is an example of a medicine inducing nephrolithiasis.2" ;
                                     rdfs:label "Acute renal failure pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionCasesWithAlternativeCausesForARF
:CasesWithAlternativeCausesForARF rdf:type owl:NamedIndividual ,
                                           obo:OAE_0001182 ,
                                           OpenPVSignal:Case_Report_Information ;
                                  OpenPVSignal:has_content "In four cases, the influence of levetiracetam in relation to the impaired renal function could not entirely be ruled out. The cases had a reasonable time to onset (3, 5, 4, 17 days) and a positive dechallenge, but levetiracetam was co-reported with drugs known to cause renal problems. One case started and stopped aciclovir during the same dates as levetiracetam. In the second case, the creatinine values peaked when the doses were highest for the suspect drugs levetiracetam, topiramate, and thiopental, and started to decrease when topiramate was withdrawn, followed by a continuous decrease after stopping levetiracetam and thiopental some days later. The third case was a 7-week-old premature baby with a complex history, who recovered from increased creatinine levels three weeks after levetiracetam had been stopped and one week after dose reduction of meropenem, which is listed with renal disorders. The fourth case was a published case reporting a suspected interaction between methotrexate and levetiracetam and where the time to onset for levetiracetam was uncertain but most likely three days.5 In two reports, the increased creatinine and renal impairment was most probably the secondary event to DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms), which is listed in the product information for levetiracetam.1 These cases had additional co-suspected AEDs: phenytoin, lacosamide and valproic acid, also known to be reported with DRESS-syndrome." ;
                                  rdfs:label "Cases with alternative causes for ARF" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionConclusionContent
:ConclusionContent rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Conclusion ;
                   OpenPVSignal:has_content "The majority of the cases included in the evaluated case series had alternative explanations for the renal impairment such as other drugs; confounding factors such as prematurity; or occurred secondary to DRESS or rhabdomyolysis. However, nine cases supported the hypothesis of a possible causal relationship between levetiracetam and impaired renal function. The pharmacological mechanism behind this signal needs to be further elucidated." ;
                   rdfs:label "Conclusion content" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionCreatinine_blood_increased
:Creatinine_blood_increased rdf:type owl:NamedIndividual ,
                                     OpenPVSignal:Adverse_Effect ;
                            OpenPVSignal:has_MedDRA_code 10011361 ;
                            OpenPVSignal:has_MedDRA_prefered_term "Creatinine blood increased" ;
                            rdfs:label "creatinine blood increased" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDiscussion
:Discussion rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Discussion ;
            mp:references :Ref.11 ,
                          :Ref.12 ,
                          :Ref.14 ,
                          :Ref.4 ,
                          :Ref.5 ,
                          :Ref.8 ,
                          :Ref.9 ;
            OpenPVSignal:has_content """Discussion
More than 100 reports with levetiracetam and ARF and/or interstitial nephritis have been reported to VigiBaseÂ® and several related published cases have been highlighted in the literature.4,5,8,9,12 The high number of reports in itself creates a suspicion of a possible nephrotoxic effect from levetiracetam. However, in many of the evaluated VigiBaseÂ® reports, levetiracetam was reported with other co-suspect drugs known to cause nephrotoxicity. The reported ARF was part of a more complex disease process in many of the reports, such as rhabdomyolysis in association with status epilepticus, and DRESS-syndrome. When it comes to the quality of data, duplication of reports was a particular obstacle in the assessment of these reports. More than 50 duplicate reports were found among the evaluated reports that to a large extent were generated from three published case reports, and there might be more duplicates among the unassessed adult cases. However, in nine of the 39 evaluated unique reports, we found support for at least a possible causal relationship between levetiracetam and impaired renal function.
ARF was reported more frequently than expected for adolescents (12-17 years) and young adults (18-44 years). However, the IC in the adolescent age group is most likely driven by the high number of duplicates from the 17-year-old and 12-year-old published cases.4,8 Reports with levetiracetam and interstitial nephritis was reported more frequently than expected based on the overall reporting in VigiBaseÂ®, although this case series also included many duplicates.
ARF is not a well-defined reaction but support for a more specific event was found for interstitial nephritis, reported for some of the ARF cases and also singly in the reports under assessment. The short time to onset for some of the cases suggests an allergic response to the drug, which supports the case of interstitial nephritis. Possible toxicity to the renal tubules in connection to levetiracetam- induced hypokalaemia and hypomagnesaemia was suggested in a published case,11 additional to this reviewed case series. In the evaluated VigiBaseÂ® reports in this assessment, there was no mentioning of kidney stone formation but more so of allergic nephritis or interstitial nephritis.
A temporal relationship was reasonable in most reports where a time to onset could be calculated. The time to onset ranged from one day to two months among the nine cases that supported a possible relationship. The time to onset of two months related to a case with increasing dose during this time period.9
Experimental evidence for this signal was supported by several cases from VigiBaseÂ® and the literature where the renal impairment improved after the drug had been withdrawn and where some reports described normal creatinine before start of levetiracetam, followed by an increase after treatment and a decrease when levetiracetam was withdrawn. Also, biological plausibility was suggested in cases where the increasing dose seemed to have triggered the development of the renal event.
There is insufficient information to be certain of the pathophysiology of levetiracetam toxicity on the kidney. The placebo-controlled clinical studies summarised for the Keppra product,14 with over 700 levetiracetam-treated patients, did not highlight any statistically significant laboratory findings, although in open studies abnormal values in haematocrit, haemoglobin, white blood cell counts and eosinophil counts were found.
Creatinine levels were not mentioned. These studies might however include too few patients in order to detect ARF and particularly interstitial nephritis.
It should be noted that only a subset of the 90 VigiBaseÂ® reports with ARF for adults were assessed in this review and that full details of the reports were only assessed for the paediatric reports, so additional supporting cases might exist.

""" ;
            rdfs:label "Discussion" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose1
:Dose1 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :levetiracetam ;
       OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 500 ;
       OpenPVSignal:refers_to_dose_value "500 mg" ;
       rdfs:label "Dose 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose11
:Dose11 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 2000 ;
        OpenPVSignal:refers_to_dose_value "2000 mg" ;
        rdfs:label "Dose 11" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose3
:Dose3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :levetiracetam ;
       OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 54 ;
       OpenPVSignal:refers_to_dose_value "54 mg" ;
       rdfs:label "Dose 3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose5
:Dose5 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :levetiracetam ;
       OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 250 ;
       OpenPVSignal:refers_to_dose_value "250 mg" ;
       rdfs:label "Dose 5a" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose6
:Dose6 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :levetiracetam ;
       OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 500 ;
       OpenPVSignal:refers_to_dose_value "500 mg" ;
       rdfs:label "Dose 6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose7
:Dose7 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :levetiracetam ;
       OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 750 ;
       OpenPVSignal:refers_to_dose_value "750 mg" ;
       rdfs:label "Dose 7a" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose8
:Dose8 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :levetiracetam ;
       OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 1000 ;
       OpenPVSignal:refers_to_dose_value "1000 mg" ;
       rdfs:label "Dose 8" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose9
:Dose9 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :levetiracetam ;
       OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 1000 ;
       OpenPVSignal:refers_to_dose_value "1000 mg" ;
       rdfs:label "Dose 9a" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose_5b
:Dose_5b rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Dosage ;
         OpenPVSignal:refers_to_drug :levetiracetam ;
         OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
         OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
         OpenPVSignal:has_value 500 ;
         OpenPVSignal:refers_to_dose_value "500 mg" ;
         rdfs:label "Dose 5b" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose_7b
:Dose_7b rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Dosage ;
         OpenPVSignal:refers_to_drug :levetiracetam ;
         OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
         OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
         OpenPVSignal:has_value 1000 ;
         OpenPVSignal:refers_to_dose_value "1000 mg" ;
         rdfs:label "Dose 7b" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDose_9b
:Dose_9b rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Dosage ;
         OpenPVSignal:refers_to_drug :levetiracetam ;
         OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
         OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
         OpenPVSignal:has_value 3000 ;
         OpenPVSignal:refers_to_dose_value "3000 mg" ;
         rdfs:label "Dose 9b" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDr_Imti_Choonara
:Dr_Imti_Choonara rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Author ;
                  OpenPVSignal:has_first_name "Imti" ;
                  OpenPVSignal:has_last_name "Choonara" ;
                  rdfs:label "Dr Imti Choonara" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionDr_Kristina_Star
:Dr_Kristina_Star rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Author ;
                  OpenPVSignal:has_affiliation "Uppsala Monitoring Centre" ;
                  OpenPVSignal:has_first_name "Kristina" ;
                  OpenPVSignal:has_last_name "Star" ;
                  rdfs:label "Dr Kristina Star" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionIC0_for_levetiracetam_and_renal_failure_acute_for_12-17_yo
:IC0_for_levetiracetam_and_renal_failure_acute_for_12-17_yo rdf:type owl:NamedIndividual ,
                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                                            OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                                                            OpenPVSignal:refers_to_drug :levetiracetam ;
                                                            OpenPVSignal:refers_to_information_component :IC_for_levetiracetam_and_renal_failure_acute_for_12-17_yo ;
                                                            OpenPVSignal:has_value 1.63 ;
                                                            rdfs:label "IC025 for levetiracetam and renal failure acute for 12-17 yo" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionIC_for_levetiracetam_and_nephritis_interstitial
:IC_for_levetiracetam_and_nephritis_interstitial rdf:type owl:NamedIndividual ,
                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                                                 OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ;
                                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                                 OpenPVSignal:has_value 2.43 ;
                                                 rdfs:label "IC for levetiracetam and nephritis interstitial" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionIC_for_levetiracetam_and_renal_failure_acute_for_12-17_yo
:IC_for_levetiracetam_and_renal_failure_acute_for_12-17_yo rdf:type owl:NamedIndividual ,
                                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                                                           OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                                                           OpenPVSignal:refers_to_drug :levetiracetam ;
                                                           OpenPVSignal:has_value 2.28 ;
                                                           rdfs:label "IC for levetiracetam and renal failure acute for 12-17 yo" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionIC_for_levetiracetam_and_renal_failure_acute_for_18-44_yo
:IC_for_levetiracetam_and_renal_failure_acute_for_18-44_yo rdf:type owl:NamedIndividual ,
                                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                                                           OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                                                           OpenPVSignal:refers_to_drug :levetiracetam ;
                                                           OpenPVSignal:has_value 1.05 ;
                                                           rdfs:label "IC for levetiracetam and renal failure acute for 18-44 yo" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionIC_for_levetiracetam_and_renal_failure_acute_for_18-44_yov
:IC_for_levetiracetam_and_renal_failure_acute_for_18-44_yov rdf:type owl:NamedIndividual ,
                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                                            OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                                                            OpenPVSignal:refers_to_drug :levetiracetam ;
                                                            OpenPVSignal:refers_to_information_component :IC_for_levetiracetam_and_renal_failure_acute_for_18-44_yo ;
                                                            OpenPVSignal:has_value 0.59 ;
                                                            rdfs:label "IC025 for levetiracetam and renal failure acute for 18-44 yo" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionICdor_levetiracetam_and_nephritis_interstitial
:ICdor_levetiracetam_and_nephritis_interstitial rdf:type owl:NamedIndividual ,
                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                                OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ;
                                                OpenPVSignal:refers_to_drug :levetiracetam ;
                                                OpenPVSignal:refers_to_information_component :IC_for_levetiracetam_and_nephritis_interstitial ;
                                                OpenPVSignal:has_value 2.01 ;
                                                rdfs:label "IC025 for levetiracetam and nephritis interstitial" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionIntroductionContent
:IntroductionContent rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Introduction ;
                     mp:references :Ref.1 ,
                                   :Ref.2 ;
                     OpenPVSignal:has_content """Levetiracetam is one of the newer generation antiepileptic drugs (AEDs). It is considered to be safer than many of the older AEDs. It is an effective anticonvulsant and its main adverse drug reactions are tiredness and behavioural changes. The active substance of levetiracetam is a pyrrolidone derivate. The mechanism of action is not fully elucidated but in vitro studies suggest that an interaction between levetiracetam and the synaptic vesicle protein 2A results in antiseizure activity. Levetiracetam is excreted primarily via urine by glomerular filtration followed by tubular reabsorption. Elimination of levetiracetam is correlated to creatinine clearance.1
Acute renal failure (ARF) is a life-threatening condition. Renal insufficiency is impairment of renal function that is less severe. ARF can be classified as: prerenal ARF with diminishing circulating arterial volume caused by conditions such as dehydration, sepsis and cardiac failure; or intrinsic renal ARF with renal parenchymal damage resulting from glomerulonephritis, rhabdomyolysis, acute interstitial nephritis; or postrenal ARF with obstruction to the urinary tract from for example tumors or posterior urethral valves. Medicines can negatively affect the renal function directly by reducing the blood flow, or indirectly by inducing for example allergic reactions to the renal tissues. Examples of nephrotoxic medicines that are known to cause ARF are aminoglycosides, acetaminophen, cisplatin, lithium, and vancomycin. Medicines known to induce interstitial nephritis are antimicrobials (e.g. cephalosporins, penicillins and sulphonamides), NSAIDs, diuretics and certain anticonvulsants (carbamazepine, phenytoin). Topiramate is an example of a medicine inducing nephrolithiasis.2""" ;
                     rdfs:label "Introduction content" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionKeppraProductInfo
:KeppraProductInfo rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Clinical_trial_information ;
                   rdfs:label "Keppra product info" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionLevetiracetam_and_impaired_renal_function
:Levetiracetam_and_impaired_renal_function rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Pharmacovigilance_Signal_Report ;
                                           OpenPVSignal:refers_to_author :Dr_Imti_Choonara ,
                                                                         :Dr_Kristina_Star ;
                                           OpenPVSignal:refers_to_signal :pvSignal ;
                                           mp:publishedBy :Uppsala_Monitoring_Centre ;
                                           OpenPVSignal:has_creation_date "01/04/2016" ;
                                           OpenPVSignal:has_overall_conclusion "causal association probable" ;
                                           rdfs:label "Levetiracetam and impaired renal function" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionLiteratureAndLabelling
:LiteratureAndLabelling rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Literature_information ;
                        mp:references :Ref.1 ,
                                      :Ref.10 ,
                                      :Ref.11 ,
                                      :Ref.12 ,
                                      :Ref.13 ,
                                      :Ref.4 ,
                                      :Ref.8 ,
                                      :Ref.9 ;
                        OpenPVSignal:has_content """In addition to the published case reports on levetiracetam with ARF and/or interstitial nephritis4,8,9 included in this assessment, there is a possible renal tubular disorder reported in a 23- year-old male who developed hypokalaemia and hypomagnesaemia but had normal serum creatinine.11 Another 23-year-old received
1000 mg levetiracetam and 2 mg lorazepam at the hospital for new onset seizures.12 Creatinine was normal before admission to hospital and started to increase the following day. Patient recovered after stopping levetiracetam and changing to phenytoin. A 69-year-old woman, who after two weeks treatment with levetiracetam presented with severe mouth mucosal ulceration secondary to herpes simplex virus, and feeling unwell with wide spread rash, elevated creatinine, leukocyte count and because of worsening azotaemia she needed haemodialysis. Levetiracetam was changed to valproic acid and her renal function gradually improved.10
Impaired renal function or related events are not described as adverse reactions in the product information for levetiracetam.1,13""" ;
                        rdfs:label "Literature and Labelling" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionNSAIDs
:NSAIDs rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Drug ;
        OpenPVSignal:has_ATC_code "M01AE" ;
        rdfs:label "NSAIDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient1
:Patient1 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 17 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient10
:Patient10 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 16 ;
           rdfs:label "Patient 10" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient11
:Patient11 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 52 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient with nephritis interstitial 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient12
:Patient12 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 37 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient with nephritis interstitial 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient13
:Patient13 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 32 ;
           rdfs:label "Patient 13" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient2
:Patient2 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 12 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient3
:Patient3 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age "0.115"^^xsd:float ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient4
:Patient4 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 73 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient5
:Patient5 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 21 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient6
:Patient6 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 60 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient7
:Patient7 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 20 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient8
:Patient8 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 45 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPatient9
:Patient9 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 45 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPetit_mal_epilepsy
:Petit_mal_epilepsy rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Indication ;
                    OpenPVSignal:has_MedDRA_code 10034759 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Petit mal epilepsy" ;
                    rdfs:label "petit mal epilepsy" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionPharmacology_of_levetiracetam
:Pharmacology_of_levetiracetam rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Mechanism ;
                               mp:references :Ref.1 ;
                               OpenPVSignal:has_content "Levetiracetam is one of the newer generation antiepileptic drugs (AEDs). It is considered to be safer than many of the older AEDs. It is an effective anticonvulsant and its main adverse drug reactions are tiredness and behavioural changes. The active substance of levetiracetam is a pyrrolidone derivate. The mechanism of action is not fully elucidated but in vitro studies suggest that an interaction between levetiracetam and the synaptic vesicle protein 2A results in antiseizure activity. Levetiracetam is excreted primarily via urine by glomerular filtration followed by tubular reabsorption. Elimination of levetiracetam is correlated to creatinine clearance.1" ;
                               rdfs:label "Pharmacology of levetiracetam" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.1
:Ref.1 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Electronic Medicines Compendium. Summary of Product Characteristics for levetiracetam (KeppraÂ®). URL: http://www.medicines.org.uk/emc/. Accessed: May 2015." ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.10
:Ref.10 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content """Chau K, Yong J, Ismail K, Griffith N, Liu M,
Makris. Levetiracetam-induced severe acute
granulomatous interstitial nephritis. Clin
Kidney J. 2012;5:234-6.""" ;
        rdfs:label "Ref.10" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.11
:Ref.11 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Aksoy D, Cevik B, Kurt S, Pekdas E, Solmaz V. Hypokalemia and hypomagnesaemia related to levetiracetam use. J Clin Neurosci. 2014;21(11):1989-90." ;
        rdfs:label "Ref.11" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.12
:Ref.12 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Spengler DC, Montouris GD, Hohler AD. Levetiracetam as a possible contributor to acute kidney injury. Clin Ther. 2014;36(8):1303-6." ;
        rdfs:label "Ref.12" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.13
:Ref.13 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "US FDA product label for levetiracetam (ELEPSIAâ¢ XR). URL: http://www.accessdata.fda.gov/scripts/cder/ drugsatfda/. Accessed: June 2015." ;
        rdfs:label "Ref.13" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.14
:Ref.14 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "European Medicines Agency. Initial marketing-authorisation documents, Keppra: EPAR-Scientific Discussion. URL: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Scientific_Discussion/human/000277/WC500041331.pdf Accessed: June 2015." ;
        rdfs:label "Ref.14" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.2
:Ref.2 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Vogt B, Avner E. Acute renal failure. in Nelson textbook of pediatrics. Kliegman R, Behrman R, Jenson H, Stanton B, Editors. 2007;Saunders Elsevier: United States of America. 2206-2207." ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.3
:Ref.3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Bergvall T, Noren GN, Lindquist M. vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues. Drug Saf. 2014;37(1):65-77." ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.4
:Ref.4 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Hurwitz KA, Ingulli EG, Krous HF. Levetiracetam induced interstitial nephritis and renal failure. Pediatr Neurol. 2009;41(1):57-8." ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.5
:Ref.5 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Parentelli AS, Phulpin-Weibel A, Mansuy L, Contet A, Trechot P, Chastagner P. Drug-drug interaction between methotrexate and levetiracetam in a child treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(2):340-1." ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.6
:Ref.6 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Tang S, Lin JP, Hughes E, Siddiqui A, Lim M, Lascelles K. Encephalopathy and SCN1A mutations. Epilepsia. 2011;52(4):e26-30." ;
       rdfs:label "Ref.6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.7
:Ref.7 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Vishwanath VA, Miller LM, 3rd. What is the right dose of lacosamide in pediatric patients with intractable epilepsy? Epilepsy Behav. 2012;23(3):396-7." ;
       rdfs:label "Ref.7" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.8
:Ref.8 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Putta S, Taiwar D. Levetiracetam related encephalopathy with opsoclonus and triphasics. Neurology. 2013;80 (Meeting Abstracts):P01.045." ;
       rdfs:label "Ref.8" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionRef.9
:Ref.9 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Mahta A, Kim RY, Kesari S. Levetiracetam- induced interstitial nephritis in a patient with glioma. J Clin Neurosci. 2012;19(1):177-8." ;
       rdfs:label "Ref.9" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport1
:Report1 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :informationForCase1 ;
         OpenPVSignal:refers_to_adverse_effect :abdominalPain ,
                                               :back_pain ,
                                               :diarrhoea ,
                                               :fatigue ,
                                               :hydronephrosis ,
                                               :interstitialNephritis ,
                                               :pallor ,
                                               :renalFailureAcute ,
                                               :renalFunctionAbnormal ,
                                               :urinary_tract_stenosis ,
                                               :vomiting ;
         OpenPVSignal:refers_to_patient :Patient1 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report1 ;
         OpenPVSignal:time_to_onset :TimeToOnset1 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport11
:Report11 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :info_for_case_with_nephritis_interstitial_1 ;
          OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ;
          OpenPVSignal:refers_to_concomitant_drug :citalopram ,
                                                  :folicAcid ,
                                                  :iron ,
                                                  :simvastatin ,
                                                  :tramadol ;
          OpenPVSignal:refers_to_patient :Patient11 ;
          OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_with_nephritis_interstitial_1 ;
          OpenPVSignal:time_to_onset :timeToOnsetReport11 ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report with nephritis interstitial 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport2
:Report2 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :informationForCase2 ;
         OpenPVSignal:refers_to_adverse_effect :acidosis ,
                                               :confusion ,
                                               :drugLevelIncreased ,
                                               :dyspnoea ,
                                               :eegAbnormal ,
                                               :encephalopathy ,
                                               :medicineIneffective ,
                                               :muscleContractionsInvoluntary ,
                                               :renalFailureAcute ,
                                               :somnolence ,
                                               :tremor ;
         OpenPVSignal:refers_to_patient :Patient2 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report2 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport3
:Report3 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :informationForCase3 ;
         OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
         OpenPVSignal:refers_to_patient :Patient3 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report3 ;
         OpenPVSignal:time_to_onset :TimeToOnset3 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport4
:Report4 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :infoForCase6 ;
         OpenPVSignal:refers_to_adverse_effect :nephritis ,
                                               :renalFailureAcute ;
         OpenPVSignal:refers_to_concomitant_drug :aspirin ,
                                                 :gliclazide ,
                                                 :losartan ;
         OpenPVSignal:refers_to_patient :Patient4 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report4 ;
         OpenPVSignal:time_to_onset :TimeToOnset4 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport5
:Report5 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :infoForCase4 ;
         OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
         OpenPVSignal:refers_to_patient :Patient5 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report5 ;
         OpenPVSignal:time_to_onset :TimeToOnset5 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport6
:Report6 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :infoForCase5 ;
         OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
         OpenPVSignal:refers_to_patient :Patient6 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report6 ;
         OpenPVSignal:time_to_onset :TimeToOnset6 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport7
:Report7 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :info_for_case_7 ;
         OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ;
         OpenPVSignal:refers_to_patient :Patient7 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report7 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport8
:Report8 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :info_for_case_8 ;
         OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ,
                                               :renalAcidosisTubular ;
         OpenPVSignal:refers_to_patient :Patient8 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report8 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReport9
:Report9 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :info_for_case_9 ;
         OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ,
                                               :renalFailureAcute ;
         OpenPVSignal:refers_to_concomitant_drug :dexamethasone ,
                                                 :temozolomide ;
         OpenPVSignal:refers_to_patient :Patient9 ;
         OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
         OpenPVSignal:refers_to_reported_drug_usage :levetiracetam_usage_for_Report9 ;
         OpenPVSignal:time_to_onset :TimeToOnset9 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionReportsGroupContent
:ReportsGroupContent rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Free_text_reporting_element ;
                     mp:references :Ref.1 ,
                                   :Ref.10 ,
                                   :Ref.3 ,
                                   :Ref.4 ,
                                   :Ref.5 ,
                                   :Ref.6 ,
                                   :Ref.7 ,
                                   :Ref.8 ,
                                   :Ref.9 ;
                     OpenPVSignal:has_content "Up to February 2015, and before exclusion of duplicates, the WHO Global database of Individual Case Safety Reports, VigiBaseÂ® included 35 reports for children (0-17 years) with levetiracetam and the WHO adverse reaction terminology (ART) preferred terms (PT) âRenal failure acuteâ (n=29); âAzotaemiaâ with the included term âCreatinine blood increasedâ (n=1); and âRenal function abnormalâ with the included term âRenal impairmentâ (n=5). Original reports were used in the evaluation of the reports issued for children. A total of 90 reports for adults (â¥ 18 years), including reports where age was unspecified, with PT âRenal failure acuteâ were retrieved, of which 12 reports were well-documented, according to vigiGrade3 (score > 0.80), and further assessed in-depth. The PT âNephritis interstitialâ was co-reported in some of the reports, so a separate analysis was made on these 49 reports with any ages. Disproportionality For levetiracetam and âRenal failure acuteâ, the lower limit of the 95% credibility interval of the Information Component (IC025) was positive for the subgroups of ages 12-17 years (IC=2.28; IC025=1.63) and 18-44 years (IC=1.05; IC025=0.59), which constituted the age groups with most reports for this combination. The IC was not positive for âRenal failure acuteâ when basing the calculation on the full database. The IC for levetiracetam and âNephritis interstitialâ was 2.43 (IC025=2.01) based on the full database. Renal failure in children After removal of 21 duplicates, 14 reports on children from five countries remained and were evaluated more in-depth. Four cases were reported with ARF, of which one also had interstitial nephritis, six with renal failure, three with creatinine increased, and one with renal impairment. Five reports referred to published case reports.4-8 Ages ranged from 6 weeks to 17 years with a median of 10.5 years. Seven reports were for females, five for males, and gender was not specified in two reports. Levetiracetam was reported as the single suspect drug in six reports. Nine cases were co-reported with other AEDs: lacosamide (n=4), valproic acid (n=3), phenobarbital (n=3), diazepam (n=3), lamotrigine (n=2), phenytoin (n=2), thiopental (n=2), topiramate (n=1), clonazepam (n=1), and clobazam (n=1). Note that one report can be reported with more than one AED. Hepatic disorders were co-reported in five reports. The daily dose was recorded in nine reports and ranged from 54 mg for a 6-week-old premature baby to 2000 mg for one of the 17-year-old cases. Three cases where levetiracetam was reported as the single suspect drug with a positive dechallenge: A 17-year-old published female case report (case 1), resulting in eight duplicate reports, had the most likely causal relationship.4 The patient had been treated with levetiracetam for 10 days when diagnosed with ARF and biopsy-confirmed interstitial nephritis. She sought health care because of vomiting, loose stools and abdominal pain for the past two days. Creatinine levels were normal before she started levetiracetam and declined after withdrawal of the drug and treatment with prednisone. The authors of this publication stated that she had no prior history of renal problems or used other medications that could have explained the event. A 12-year-old female (case 2) was admitted to hospital for ARF, metabolic acidosis, respiratory distress and confusion, which was described in a published abstract.8 A few hours after admission she became encephalopathic. Levetiracetam levels were found to be high and the probable cause of encephalopathy. Levetiracetam was stopped and replaced with valproate and patient improved after about five days. The focus in the abstract was on the encephalopathy, and it was unclear what the origin of the ARF was. A 6-week-old premature baby (case 3) was diagnosed with ARF after 16 days treatment with levetiracetam. Reaction abated when the drug was withdrawn. Prematurity could contribute to the susceptibility. Further information on the above cases is given in Table 1. In another report, where levetiracetam was the single suspect drug, a 16-year-old was described to be hospitalized for encephalopathy and chorea. The patient was placed on phenytoin, and then transitioned to valproic acid and later to levetiracetam. Serum creatinine started to increase thereafter. This report did not include any other co-reported drugs. Time to onset and dechallenge information was missing for this report. Another six cases included alternative causes for the ARF: In four cases, the influence of levetiracetam in relation to the impaired renal function could not entirely be ruled out. The cases had a reasonable time to onset (3, 5, 4, 17 days) and a positive dechallenge, but levetiracetam was co-reported with drugs known to cause renal problems. One case started and stopped aciclovir during the same dates as levetiracetam. In the second case, the creatinine values peaked when the doses were highest for the suspect drugs levetiracetam, topiramate, and thiopental, and started to decrease when topiramate was withdrawn, followed by a continuous decrease after stopping levetiracetam and thiopental some days later. The third case was a 7-week-old premature baby with a complex history, who recovered from increased creatinine levels three weeks after levetiracetam had been stopped and one week after dose reduction of meropenem, which is listed with renal disorders. The fourth case was a published case reporting a suspected interaction between methotrexate and levetiracetam and where the time to onset for levetiracetam was uncertain but most likely three days.5 In two reports, the increased creatinine and renal impairment was most probably the secondary event to DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms), which is listed in the product information for levetiracetam.1 These cases had additional co-suspected AEDs: phenytoin, lacosamide and valproic acid, also known to be reported with DRESS-syndrome. One report was unassessable because of lack of information. In three cases, levetiracetam was most likely not related to the ARF, in which two reported fatal outcome: A 9-year-old male experienced status epilepticus with metabolic acidosis and developed rhabdomyolysis and hepatorenal failure.6 A 3-year-old female where the focus was on status epilepticus and the sudden interruption of lacosamide treatment.7 Renal failure in adults A total of 90 reports for adults, or with unknown age, with levetiracetam and the WHO-ART PT âRenal failure acuteâ have been received from 11 countries in North America, Europe, Oceania and Asia. Twelve of the 90 reports were well-documented according to vigiGrade3 (score > 0.80) and were included in the analysis. Ten cases reported ARF, one renal failure, and another renal insufficiency. Ages ranged from 21 to 73 years with a median of 45 years. Five reports were for females and seven for males. Levetiracetam was reported as the single suspect drug in five reports. Six cases were co-reported with other AEDs: lamotrigine (n=3), valproic acid (n=2), phenytoin (n=2), clonazepam (n=1), clobazam (n=1), oxcarbazepine (n=1), lacosamide (n=1); one report can be recorded with more than one AED. In eight reports, the reaction abated after drug withdrawal. Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days. The patient with the longest time to onset had a history of chronic renal impairment, and where the primary reported concern was long QT syndrome. Three of the cases reported with an increasing creatinine value in connection to levetiracetam start, followed by a reduction to normal after withdrawal of levetiracetam: A 21-year-old male received levetiracetam 250 mg per day at the start of the month (exact time not given). On the 24th, the dose was increased to 500 mg per day and clobazam was added to the regimen. Two days thereafter, a five-fold increase in the creatinine was observed along with an abnormal creatine phosphokinase (CPK). Creatinine continued to increase during two more days reaching a 10- fold increase together with an increased CPK. Levetiracetam was discontinued (no date) and replaced with lamotrigine (clobazam was continued). Patient recovered. In a 60-year-old female; the creatinine had doubled on the fourth day of treatment with levetiracetam compared with the day of treatment start. Two days thereafter, levetiracetam was withdrawn followed by a decreasing creatinine. Patient recovered fully five days after levetiracetam withdrawal. A 73-year-old male presented at hospital with convulsions and started with levetiracetam, at which time creatinine was normal. Patient had a long-time treatment history of glicazide, losartan and aspirin. The day after levetiracetam start, the creatinine had almost doubled. Two days later the creatinine was still elevated. Renal echography was normal. An allergic nephritis was suspected. Levetiracetam, gliclazide and aspirin (unclear if also losartan) was stopped and the next day the creatinine had decreased and was normal five days thereafter. Patient started with carbamazepine and re-started losartan and gliclazide. See Table 1, for further information on these cases (4-6). In seven cases, alternative causes for the renal failure or insufficiency were reported, such as other drugs (n=2); other main events associated with the renal failure (DRESS syndrome (n=2), rhabdomyolysis and status epilepticus (n=1)), or confounding factors such as cancer (n=2). Two cases were reported with QT prolongation in connection to the renal failure. Interstitial nephritis in children and adults Forty-nine reports with levetiracetam and âNephritis interstitialâ were retrieved from VigiBase. Among the reports for children, one report had already been accounted for in the review of ARF and the remaining 17 reports were likely duplicates with the published 17-year-old female.4 For the adults, or reports without a given age, 13 reports were evaluated following removal of 16 duplicate reports of another published case of a 45-year-old,9 and additionally two duplicates for other cases. Ages ranged from 20 to 76 years with a median of 51 years. Nine reports were for males and four for females. Levetiracetam was reported as the single suspect drug in six reports. Five cases were co-reported with other AEDs: valproic acid (n=5), carbamazepine (n=2), topiramate (n=1), clobazam (n=1); one report can be recorded with more than one AED. In five reports, the reaction abated after drug withdrawal. Time to onset could be assessed in five reports and ranged from 1 to 12 months. In three reports, levetiracetam was reported as the single suspect drug with a positive dechallenge. See Table 1 and cases 7-9 for more information. In two cases levetiracetam was reported as the single suspect drug with a long time to onset and lacked complete dechallenge information. A 52-year-old female was diagnosed with interstitial nephritis after five months treatment with levetiracetam 2000 mg daily. Drug was stopped 10 months after event start. Patient had not recovered at the time of report. Reported concomitant drugs were: tramadol, citalopram, simvastatin, folic acid and iron. No dates were given for these drugs. A 37-year-old male was diagnosed with interstitial nephritis and renal interstitial fibrosis after about four months of treatment with levetiracetam. It is unknown if the drug was stopped. Patient had not recovered at the time of report. Reported concomitant drugs were: valproic acid and carbamazepine. No dates were given for these drugs. In another report, levetiracetam was the single suspect drug and most likely the spontaneously reported published 69-year-old case described later in this signal.10 In three reports, levetiracetam was co-suspect with other drugs but because dates were lacking it was not possible to assess which of the drugs were more likely to have induced the event. The co-suspect drugs were valproic acid, topiramate, fluconazole. Interstitial nephritis is not labelled for any of these drugs. In three additional reports, the co-suspect drugs; melperone, oesomeprazole and carbamazepine, respectively, were more likely the drugs inducing the interstitial nephritis in these cases. The main event for a 32-year-old was DRESS syndrome that was co-reported with the interstitial nephritis. Co-suspect drugs for this patient were vancomycin and valproic acid." ;
                     rdfs:label "Reports in Vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionSummaryContent
:SummaryContent rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Summary ;
                OpenPVSignal:has_content """Levetiracetam and acute renal failure (ARF) was highlighted as a potential signal in the paediatric signal detection sprint. The paediatric population and ARF was the starting point for this assessment but the signal expanded to cover reports of all ages as well as encompassing interstitial nephritis. There are more than 150 reports on levetiracetam with ARF and/or interstitial nephritis in the WHO Global database of Individual Case Safety Reports,, VigiBaseÂ®, although many of these reports turned out to be duplicates. We assessed a subset of 39 reports more in-depth and found reports supporting a possible causal relationship between levetiracetam and impaired renal function, and more specifically, interstitial nephritis. Impaired renal function or related events are not described as adverse reactions in the product information for levetiracetam.
Although these events may occur only rarely, it would be beneficial to inform clinicians that levetiracetam has the potential to impair renal function.""" ;
                rdfs:label "Summary content" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionTimeToOnset1
:TimeToOnset1 rdf:type owl:NamedIndividual ,
                       time:DurationDescription ;
              OpenPVSignal:has_content "10 days" ;
              time:nominalPosition "days" ;
              time:numericPosition 10 ;
              rdfs:label "Time to onset 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionTimeToOnset3
:TimeToOnset3 rdf:type owl:NamedIndividual ,
                       time:DurationDescription ;
              OpenPVSignal:has_content "16 days" ;
              time:nominalPosition "days" ;
              time:numericPosition 16 ;
              rdfs:label "Time to onset 3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionTimeToOnset4
:TimeToOnset4 rdf:type owl:NamedIndividual ,
                       time:DurationDescription ;
              OpenPVSignal:has_content "1 day" ;
              time:nominalPosition "days" ;
              time:numericPosition 1 ;
              rdfs:label "Time to onset 4" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionTimeToOnset5
:TimeToOnset5 rdf:type owl:NamedIndividual ,
                       time:DurationDescription ;
              OpenPVSignal:has_content "~20 days" ;
              time:nominalPosition "days" ;
              time:numericPosition 20 ;
              rdfs:label "Time to onset 5" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionTimeToOnset6
:TimeToOnset6 rdf:type owl:NamedIndividual ,
                       time:DurationDescription ;
              OpenPVSignal:has_content "4 days" ;
              time:nominalPosition "days" ;
              time:numericPosition 4 ;
              rdfs:label "Time to onset 6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionTimeToOnset9
:TimeToOnset9 rdf:type owl:NamedIndividual ,
                       time:DurationDescription ;
              OpenPVSignal:has_content "2 months" ;
              time:nominalPosition "months" ;
              time:numericPosition 2 ;
              rdfs:label "Time to onset 9" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionUppsala_Monitoring_Centre
:Uppsala_Monitoring_Centre rdf:type owl:NamedIndividual ,
                                    prov:Organization ;
                           rdfs:label "Uppsala Monitoring Centre" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionabdominalPain
:abdominalPain rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "R10.9" ;
               OpenPVSignal:has_MedDRA_code 10000081 ;
               OpenPVSignal:has_MedDRA_prefered_term "Abdominal pain" ;
               rdfs:label "abdominal pain" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionacetaminophen
:acetaminophen rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N02BE01" ;
               rdfs:label "acetaminophen" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionacidosis
:acidosis rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "E87.2" ;
          OpenPVSignal:has_MedDRA_code 10000486 ;
          OpenPVSignal:has_MedDRA_prefered_term "Acidosis" ;
          rdfs:label "acidosis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionacuteRenalFailure
:acuteRenalFailure rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "N17.9" ;
                   OpenPVSignal:has_MedDRA_code 10069339 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Acute kidney injury" ;
                   rdfs:label "acute renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionaminoglycosides
:aminoglycosides rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "J01G" ;
                 rdfs:label "aminoglycosides" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionaspirin
:aspirin rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "B01AC06Â " ;
         rdfs:label "aspirin" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionazotaemia
:azotaemia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10003885 ;
           OpenPVSignal:has_MedDRA_prefered_term "Azotaemia" ;
           rdfs:label "azotaemia" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionback_pain
:back_pain rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10003988 ;
           OpenPVSignal:has_MedDRA_prefered_term "Back pain" ;
           rdfs:label "back pain" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionbehaviouralChanges
:behaviouralChanges rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "R46.89" ;
                    OpenPVSignal:has_MedDRA_code 10004210 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Behavioural disorder" ;
                    rdfs:label "behavioural changes" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionbloodCreatinineIncreased
:bloodCreatinineIncreased rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_ICD_code "R79.89" ;
                          OpenPVSignal:has_MedDRA_code 10005483 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Blood creatinine increased" ;
                          rdfs:label "blood creatinine increased" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioncancer
:cancer rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_MedDRA_code 10007050 ;
        OpenPVSignal:has_MedDRA_prefered_term "Cancer" ;
        rdfs:label "cancer" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioncarbamazepine
:carbamazepine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N03AF01" ;
               rdfs:label "carbamazepine" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioncephalosporins
:cephalosporins rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "J01DB" ,
                                          "J01DC" ,
                                          "J01DD" ,
                                          "J01DE" ;
                rdfs:label "cephalosporins" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioncisplatin
:cisplatin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01XA01" ;
           rdfs:label "cisplatin" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioncitalopram
:citalopram rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N06AB04Â " ;
            rdfs:label "citalopram" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionclobazam
:clobazam rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N05BA09" ;
          rdfs:label "clobazam" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionclonazepam
:clonazepam rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AE01" ;
            rdfs:label "clonazepam" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionconfusion
:confusion rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R41.0" ;
           OpenPVSignal:has_MedDRA_code 10010305 ;
           OpenPVSignal:has_MedDRA_prefered_term "Confusional state" ;
           rdfs:label "confusion" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionconvuslion
:convuslion rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Indication ;
            OpenPVSignal:has_MedDRA_code 10010904 ;
            OpenPVSignal:has_MedDRA_prefered_term "Convulsion" ;
            rdfs:label "convulsion" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondexamethasone
:dexamethasone rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "A01AC02" ,
                                         "C05AA09" ,
                                         "D07AB19" ,
                                         "D07CB04" ,
                                         "D07XB05" ,
                                         "D10AA03" ,
                                         "H02AB02" ,
                                         "R01AD03" ,
                                         "R01AD53" ,
                                         "S01BA01" ,
                                         "S01CA01" ,
                                         "S01CB01" ,
                                         "S02BA06" ,
                                         "S02CA06" ,
                                         "S03BA01" ,
                                         "S03CA01" ;
               rdfs:label "dexamethasone" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondiarrhoea
:diarrhoea rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "Â R19.7" ;
           OpenPVSignal:has_MedDRA_code 10012735 ;
           OpenPVSignal:has_MedDRA_prefered_term "Diarrhoea" ;
           rdfs:label "diarrhoea" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondiazepam
:diazepam rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N05BA01" ;
          rdfs:label "diazepam" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondiuretics
:diuretics rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C03" ;
           rdfs:label "diuretics" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondose_for_report_with_nephritis_interstitial_1
:dose_for_report_with_nephritis_interstitial_1 rdf:type owl:NamedIndividual ,
                                                        OpenPVSignal:Dosage ;
                                               OpenPVSignal:refers_to_drug :levetiracetam ;
                                               OpenPVSignal:refers_to_interval_between_administrations :oneDayIntervalsBetweenAdministrations ;
                                               OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                                               OpenPVSignal:has_value 2000 ;
                                               OpenPVSignal:refers_to_dose_value "2000 mg" ;
                                               rdfs:label "dose for report with nephritis interstitial 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondose_info
:dose_info rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Dosage ;
           OpenPVSignal:has_content "The daily dose was recorded in nine reports and ranged from 54 mg for a 6-week-old premature baby to 2000 mg for one of the 17-year-old cases." ;
           rdfs:label "dose info" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondressSyndrome
:dressSyndrome rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_MedDRA_code 10073508 ;
               OpenPVSignal:has_MedDRA_prefered_term "Drug reaction with eosinophilia and systemic symptoms" ;
               rdfs:label "dress syndrome" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondrugLevelIncreased
:drugLevelIncreased rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "Â R89.2" ;
                    OpenPVSignal:has_MedDRA_code 10013722 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Drug level increased" ;
                    rdfs:label "drug level increased" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiondyspnoea
:dyspnoea rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "Â R06.00" ;
          OpenPVSignal:has_MedDRA_code 10013968 ;
          OpenPVSignal:has_MedDRA_prefered_term "Dyspnoea" ;
          rdfs:label "dyspnoea" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioneegAbnormal
:eegAbnormal rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "R94.01" ;
             OpenPVSignal:has_MedDRA_code 10014408 ;
             OpenPVSignal:has_MedDRA_prefered_term "Electroencephalogram abnormal" ;
             rdfs:label "eeg abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionencephalopathy
:encephalopathy rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "G93.40" ;
                OpenPVSignal:has_MedDRA_code 10014625 ;
                OpenPVSignal:has_MedDRA_prefered_term "Encephalopathy" ;
                rdfs:label "encephalopathy" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionepilepsy
:epilepsy rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Indication ;
          OpenPVSignal:has_ICD_code "G40.909" ;
          OpenPVSignal:has_MedDRA_code 10015037 ;
          OpenPVSignal:has_MedDRA_prefered_term "Epilepsy" ;
          rdfs:label "epilepsy" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionfatigue
:fatigue rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "R53.83" ;
         OpenPVSignal:has_MedDRA_code 10016256 ;
         OpenPVSignal:has_MedDRA_prefered_term "Fatigue" ;
         rdfs:label "fatigue" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionfolicAcid
:folicAcid rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "B03BB51Â " ;
           rdfs:label "folic acid" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiongliclazide
:gliclazide rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A10BB09" ;
            rdfs:label "gliclazide" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionhepatic_disorders
:hepatic_disorders rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_MedDRA_code 20000005 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Hepatic disorders (SMQ)" ;
                   rdfs:label "hepatic disorders" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionhydronephrosis
:hydronephrosis rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "N13.2" ;
                OpenPVSignal:has_MedDRA_code 10020524 ;
                OpenPVSignal:has_MedDRA_prefered_term "Hydronephrosis" ;
                rdfs:label "hydronephrosis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionimpairedRenalFunction
:impairedRenalFunction rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "N28.9" ;
                       OpenPVSignal:has_MedDRA_code 10062237 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Renal impairment" ;
                       rdfs:label "impaired renal function" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfoForCase4
:infoForCase4 rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "A 21-year-old male received levetiracetam 250 mg per day at the start of the month (exact time not given). On the 24th, the dose wasÂ increased to 500 mg per day and clobazam was added to the regimen. Two days thereafter, a five-fold increase in the creatinine was observed along with an abnormal creatine phosphokinase (CPK). Creatinine continued to increase during two more days reaching a 10- fold increase together with an increased CPK. Levetiracetam was discontinued (no date) and replaced with lamotrigine (clobazam was continued). Patient recovered." ,
                                       "Reaction abated after drug withdrawal." ;
              rdfs:label "info for case 5" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfoForCase5
:infoForCase5 rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "In a 60-year-old female; the creatinine had doubled on the fourth day of treatment with levetiracetam compared with the day of treatment start. Two days thereafter, levetiracetam was withdrawn followed by a decreasing creatinine. Patient recovered fully five days after levetiracetam withdrawal." ,
                                       "Reaction abated after drug withdrawal." ;
              rdfs:label "info for case 6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfoForCase6
:infoForCase6 rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "A 73-year-old male presented at hospital with convulsions and started with levetiracetam, at which time creatinine was normal. Patient had a long-time treatment history of glicazide, losartan and aspirin. The day after levetiracetam start, the creatinine had almost doubled. Two days later the creatinine was still elevated. Renal echography was normal. An allergic nephritis was suspected. Levetiracetam, gliclazide and aspirin (unclear if also losartan) was stopped and the next day the creatinine had decreased and was normal five days thereafter. Patient started with carbamazepine and re-started losartan and gliclazide." ,
                                       "Reaction abated after drug withdrawal. The patient had a history of arterial hypertension and Type 2 diabetes mellitus, and a long-time treatment with glicazide, losartan and aspirin. Losartan is known to cause renal failure." ;
              rdfs:label "info for case 4" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfo_for_another_case
:info_for_another_case rdf:type owl:NamedIndividual ,
                                obo:OAE_0001197 ,
                                OpenPVSignal:Case_Report_Information ;
                       OpenPVSignal:has_content "In another report, where levetiracetam was the single suspect drug, a 16-year-old was described to be hospitalized for encephalopathy and chorea. The patient was placed on phenytoin, and then transitioned to valproic acid and later to levetiracetam. Serum creatinine started to increase thereafter. This report did not include any other co-reported drugs. Time to onset and dechallenge information was missing for this report." ;
                       rdfs:label "info for another case" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfo_for_case_7
:info_for_case_7 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Case_Report_Information ;
                 OpenPVSignal:has_content "Reaction abated after drug withdrawal. Dates were not given for the different dosages." ;
                 rdfs:label "info for case 7" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfo_for_case_8
:info_for_case_8 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Case_Report_Information ;
                 OpenPVSignal:has_content "Reaction abated after drug withdrawal." ;
                 rdfs:label "info for case 8" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfo_for_case_9
:info_for_case_9 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Case_Report_Information ;
                 OpenPVSignal:has_content "Reaction abated after drug withdrawal. Levetiracetam was changed to lacosamide and patient improved clinically and the creatinine normalized over 1 month." ;
                 rdfs:label "info for case 9" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfo_for_case_with_nephritis_interstitial_1
:info_for_case_with_nephritis_interstitial_1 rdf:type owl:NamedIndividual ,
                                                      OpenPVSignal:Case_Report_Information ;
                                             OpenPVSignal:has_content "A 52-year-old female was diagnosed with interstitial nephritis after five months treatment with levetiracetam 2000 mg daily. Drug was stopped 10 months after event start. Patient had not recovered at the time of report. Reported concomitant drugs were: tramadol, citalopram, simvastatin, folic acid and iron. No dates were given for these drugs." ;
                                             rdfs:label "info for case with nephritis interstitial 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfo_for_case_with_nephritis_interstitial_2
:info_for_case_with_nephritis_interstitial_2 rdf:type owl:NamedIndividual ,
                                                      OpenPVSignal:Case_Report_Information ;
                                             OpenPVSignal:has_content "A 37-year-old male was diagnosed with interstitial nephritis and renal interstitial fibrosis after about four months of treatment with levetiracetam. It is unknown if the drug was stopped. Patient had not recovered at the time of report. Reported concomitant drugs were: valproic acid and carbamazepine. No dates were given for these drugs." ;
                                             rdfs:label "info for case with nephritis interstitial 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninfo_for_more_cases
:info_for_more_cases rdf:type owl:NamedIndividual ,
                              obo:OAE_0001125 ,
                              OpenPVSignal:Case_Report_Information ;
                     OpenPVSignal:has_content """In another report, levetiracetam was the single 
suspect drug and most likely the spontaneously 
reported published 69-year-old case described 
later in this signal.10
In three reports, levetiracetam was co-suspect 
with other drugs but because dates were lacking it 
was not possible to assess which of the drugs were 
more likely to have induced the event. The co-suspect drugs were valproic acid, topiramate, 
fluconazole. Interstitial nephritis is not labelled for 
any of these drugs.
In three additional reports, the co-suspect drugs; 
melperone, oesomeprazole and carbamazepine, 
respectively, were more likely the drugs inducing 
the interstitial nephritis in these cases.
The main event for a 32-year-old was DRESS 
syndrome that was co-reported with the interstitial 
nephritis. Co-suspect drugs for this patient were 
vancomycin and valproic acid.""" ;
                     rdfs:label "info for more cases" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninformationForCase1
:informationForCase1 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Case_Report_Information ;
                     OpenPVSignal:has_content """A 17-year-old published female case report (case 1), resulting in eight duplicate reports, had the most likely causal relationship.4 The patient had been treated with levetiracetam for 10 days when diagnosed with ARF and biopsy- confirmed interstitial nephritis. She sought health care because of vomiting, loose stools and abdominal pain for the past two days.
Creatinine levels were normal before she started levetiracetam and declined after withdrawal of the drug and treatment with prednisone. The authors of this publication stated that she had no prior history of renal problems or used other medications that could have explained the event.""" ,
                                              "Reaction abated after drug withdrawal and corticosteroidtreatment. No history of renal problems and no other medications. Changed antiepileptic treatment to oxcarbamazepine." ;
                     rdfs:label "info for case 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninformationForCase2
:informationForCase2 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Case_Report_Information ;
                     OpenPVSignal:has_content "A 12-year-old female (case 2) was admitted to hospital for ARF, metabolic acidosis, respiratory distress and confusion, which was described in a published abstract.8 A few hours after admission she became encephalopathic. Levetiracetam levels were found to be high and the probable cause of encephalopathy. Levetiracetam was stopped and replaced with valproate and patient improved after about five days. The focus in the abstract was on the encephalopathy, and it was unclear what the origin of the ARF was." ,
                                              "Patient returned to baseline after drug withdrawal.Unclear why she was admitted for acute renal failure. Had a history of Chiari II, myelomeningocele, shunted hydrocephalus, renal tubular acidosis and well-controlled epilepsy on levetiracetam." ;
                     rdfs:label "info for case 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninformationForCase3
:informationForCase3 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Case_Report_Information ;
                     OpenPVSignal:has_content "A 6-week-old premature baby (case 3) was diagnosed with ARF after 16 days treatment with levetiracetam. Reaction abated when the drug was withdrawn. Prematurity could contribute to the susceptibility." ,
                                              "Reaction abated after drug withdrawal. Prematurity could contribute to susceptibility. Renalfailure reported as transient." ;
                     rdfs:label "info for case 3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninterstitialNephritis
:interstitialNephritis rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_MedDRA_code 10029134 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Nephritis interstitial" ;
                       rdfs:label "nephritis interstitial" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioninterstitial_nephritis
:interstitial_nephritis rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Warning_Information ;
                        OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ;
                        OpenPVSignal:refers_to_drug :NSAIDs ,
                                                    :carbamazepine ,
                                                    :cephalosporins ,
                                                    :diuretics ,
                                                    :penicillins ,
                                                    :phenytoin ,
                                                    :sulphonamides ;
                        OpenPVSignal:has_content "Medicines known to induce interstitial nephritis are antimicrobials (e.g. cephalosporins, penicillins and sulphonamides), NSAIDs, diuretics and certain anticonvulsants (carbamazepine, phenytoin)." ;
                        rdfs:label "interstitial nephritis and drugs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functioniron
:iron rdf:type owl:NamedIndividual ,
               OpenPVSignal:Drug ;
      OpenPVSignal:has_ATC_code "B03AE" ;
      rdfs:label "iron" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlacosamide
:lacosamide rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AX18" ;
            rdfs:label "lacosamide" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlamotrigine
:lamotrigine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N03AX09" ;
             rdfs:label "lamotrigine" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam
:levetiracetam rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_mechanism :Pharmacology_of_levetiracetam ;
               OpenPVSignal:has_ATC_code "N03AX14" ;
               rdfs:label "levetiracetam" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetamAndBehaviouralChanges
:levetiracetamAndBehaviouralChanges rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Warning_Information ;
                                    OpenPVSignal:refers_to_adverse_effect :behaviouralChanges ;
                                    OpenPVSignal:refers_to_drug :levetiracetam ;
                                    mp:references :Ref.1 ;
                                    mp:citation "It is an effective anticonvulsant and its main adverse drug reactions are tiredness and behavioural changes. " ;
                                    rdfs:label "levetiracetam and behavioural changes" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetamAndTiredness
:levetiracetamAndTiredness rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Warning_Information ;
                           OpenPVSignal:refers_to_adverse_effect :tiredness ;
                           mp:references :Ref.1 ;
                           mp:citation "It is an effective anticonvulsant and its main adverse drug reactions are tiredness and behavioural changes. " ;
                           rdfs:label "levetiracetam and tiredness" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report1
:levetiracetam_usage_for_Report1 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:concerns_indication_for_use :convuslion ;
                                 OpenPVSignal:refers_to_dosage :Dose1 ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report2
:levetiracetam_usage_for_Report2 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:concerns_indication_for_use :epilepsy ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report3
:levetiracetam_usage_for_Report3 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:concerns_indication_for_use :seizure ;
                                 OpenPVSignal:refers_to_dosage :Dose3 ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report4
:levetiracetam_usage_for_Report4 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:concerns_indication_for_use :epilepsy ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 4" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report5
:levetiracetam_usage_for_Report5 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:concerns_indication_for_use :epilepsy ;
                                 OpenPVSignal:refers_to_dosage :Dose5 ,
                                                               :Dose_5b ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 5" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report6
:levetiracetam_usage_for_Report6 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:concerns_indication_for_use :Petit_mal_epilepsy ;
                                 OpenPVSignal:refers_to_dosage :Dose6 ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report7
:levetiracetam_usage_for_Report7 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:refers_to_dosage :Dose7 ,
                                                               :Dose_7b ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 7" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report8
:levetiracetam_usage_for_Report8 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:concerns_indication_for_use :epilepsy ;
                                 OpenPVSignal:refers_to_dosage :Dose8 ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 8" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlevetiracetam_usage_for_Report9
:levetiracetam_usage_for_Report9 rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Drug_Usage ;
                                 OpenPVSignal:concerns_indication_for_use :seizure ;
                                 OpenPVSignal:refers_to_dosage :Dose9 ,
                                                               :Dose_9b ;
                                 OpenPVSignal:refers_to_drug :levetiracetam ;
                                 rdfs:label "usage for report 9" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlithium
:lithium rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "N05AN01" ;
         rdfs:label "lithium" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionlosartan
:losartan rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "C09CA01" ,
                                    "C09DA01" ,
                                    "C09DB06" ;
          rdfs:label "losartan" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionmedicineIneffective
:medicineIneffective rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10013709 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Drug ineffective" ;
                     rdfs:label "medicine ineffective" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionmuscleContractionsInvoluntary
:muscleContractionsInvoluntary rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Adverse_Effect ;
                               OpenPVSignal:has_ICD_code "M62.838" ;
                               OpenPVSignal:has_MedDRA_code 10028293 ;
                               OpenPVSignal:has_MedDRA_prefered_term "Muscle contractions involuntary" ;
                               rdfs:label "muscle contractions involuntary" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionnephritis
:nephritis rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10029117 ;
           OpenPVSignal:has_MedDRA_prefered_term "Nephritis" ;
           rdfs:label "nephritis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionnephrolithiasis
:nephrolithiasis rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "N20.0" ;
                 OpenPVSignal:has_MedDRA_code 10029148 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Nephrolithiasis" ;
                 rdfs:label "nephrolithiasis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiononeDayIntervalsBetweenAdministrations
:oneDayIntervalsBetweenAdministrations rdf:type owl:NamedIndividual ,
                                                time:DurationDescription ;
                                       time:nominalPosition "days" ;
                                       time:numericPosition 1 ;
                                       rdfs:label "one day intervals between administrations" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionoverallReportsInVigibase
:overallReportsInVigibase rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:refers_to_adverse_effect :Creatinine_blood_increased ,
                                                                :azotaemia ,
                                                                :renalFailureAcute ,
                                                                :renalFunctionAbnormal ,
                                                                :renal_impairment ;
                          OpenPVSignal:refers_to_drug :levetiracetam ;
                          OpenPVSignal:has_count 35 ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          rdfs:label "overall reports in vigibase for children" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionoxcarbazepine
:oxcarbazepine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N03AF02" ;
               rdfs:label "oxcarbazepine" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionpallor
:pallor rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R23.1" ;
        OpenPVSignal:has_MedDRA_code 10033546 ;
        OpenPVSignal:has_MedDRA_prefered_term "Pallor" ;
        rdfs:label "pallor" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionpenicillins
:penicillins rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "J01C" ;
             rdfs:label "penicillins" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionphenobarbital
:phenobarbital rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N03AA02" ;
               rdfs:label "phenobarbital" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionphenytoin
:phenytoin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N03AB02" ,
                                     "N03AB52" ;
           rdfs:label "phenytoin" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionproduct_info
:product_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Structured_Product_Labels_information ;
              OpenPVSignal:refers_to_drug :levetiracetam ;
              mp:references :Ref.1 ,
                            :Ref.13 ;
              OpenPVSignal:has_content "Impaired renal function or related events are not described as adverse reactions in tthe product information for levetiracetam.1,13" ;
              rdfs:label "product info" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionpublished_cases
:published_cases rdf:type owl:NamedIndividual ,
                          obo:OAE_0001197 ;
                 mp:references :Ref.10 ,
                               :Ref.11 ,
                               :Ref.12 ,
                               :Ref.4 ,
                               :Ref.8 ,
                               :Ref.9 ;
                 OpenPVSignal:has_content "n addition to the published case reports on levetiracetam with ARF and/or interstitial nephritis4,8,9 included in this assessment, there is a possible renal tubular disorder reported in a 23- year-old male who developed hypokalaemia and hypomagnesaemia but had normal serum creatinine.11 Another 23-year-old received 1000 mg levetiracetam and 2 mg lorazepam at the hospital for new onset seizures.12 Creatinine was normal before admission to hospital and started to increase the following day. Patient recovered after stopping levetiracetam and changing to phenytoin. A 69-year-old woman, who after two weeks treatment with levetiracetam presented with severe mouth mucosal ulceration secondary to herpes simplex virus, and feeling unwell with wide spread rash, elevated creatinine, leukocyte count and because of worsening azotaemia she needed haemodialysis. Levetiracetam was changed to valproic acid and her renal function gradually improved.10" ;
                 rdfs:label "published cases" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionpvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Signal ;
          OpenPVSignal:Free_text_reporting_element :Acute_renal_failure_pathophysiology ,
                                                   :ConclusionContent ,
                                                   :Discussion ,
                                                   :IntroductionContent ,
                                                   :ReportsGroupContent ,
                                                   :SummaryContent ;
          OpenPVSignal:is_supported_by_individual_case_report :Report1 ,
                                                              :Report11 ,
                                                              :Report2 ,
                                                              :Report3 ,
                                                              :Report4 ,
                                                              :Report5 ,
                                                              :Report6 ,
                                                              :Report7 ,
                                                              :Report8 ,
                                                              :Report9 ,
                                                              :report12 ;
          OpenPVSignal:is_supported_by_statistical_entity :overallReportsInVigibase ,
                                                          :reportsForAzotaemiaAndCreatinineBloodIncreased ,
                                                          :reportsForRenalFailureAcute ,
                                                          :reportsForRenalFailureAndLevetiracetamInAdults ,
                                                          :reportsForRenalFailureAndLevetiracetamInAdults1 ,
                                                          :reportsForRenalFailureAndLevetiracetamInAdults2 ,
                                                          :reportsForRenalFailureAndLevetiracetamInAdults3 ,
                                                          :reportsForRenalFailureAndLevetiracetamInAdults4 ,
                                                          :reportsForRenalFailureAndLevetiracetamInAdults5 ,
                                                          :reportsForRenalFailureAndLevetiracetamInAdults6 ,
                                                          :reportsForRenalFailureAndLevetiracetamInAdults7 ,
                                                          :reportsForadults-interstitialNephritisChildernAndAdults ,
                                                          :reportsWithInterstitialNephritisInChildrenAndAdults ,
                                                          :reportsWithLevetiracetamAsASinglesuspect-interstitialNephritisChildernAndAdults ,
                                                          :reportsWithPositivedechallenge-interstitialNephritisChildernAndAdults ,
                                                          :reportsWithRenalFailureInChildren ,
                                                          :reportsWithRenalFailureInChildrenARF ,
                                                          :reportsWithRenalFailureInChildrenClonazepamAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenCreatinineIncreased ,
                                                          :reportsWithRenalFailureInChildrenDiazepamAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenLacosamideAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenLamotrigineAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenLevetiracetamAsTheSingleSuspect ,
                                                          :reportsWithRenalFailureInChildrenPhenobarbitalAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenPhenytoinAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenRenalFailure ,
                                                          :reportsWithRenalFailureInChildrenThiopentalAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenTopiramateAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenValproicAcidAsAEDs ,
                                                          :reportsWithRenalFailureInChildrenrenalImpairment ,
                                                          :reportsWithRenalFailureInchildren-clobazamAsAEDs ,
                                                          :reportsWithTimeToOnsetinfo-interstitialNephritisChildernAndAdults ,
                                                          :reportsWithValproicacid-interstitialNephritisChildernAndAdults ,
                                                          :reportsWithcarbamazepine-interstitialNephritisChildernAndAdults ,
                                                          :reportsWithclobazam-interstitialNephritisChildernAndAdults ,
                                                          :reportsWithtopiramate-interstitialNephritisChildernAndAdults ,
                                                          :reports_for_renal_failure_and_levetiracetam_in_adults_onset_0 ,
                                                          :reports_in_adults_status_epilepticus ,
                                                          :reports_in_children_case_reports ,
                                                          :reports_in_children_dose_info ,
                                                          :reports_in_children_hepatic_disorders ,
                                                          :reports_with_renal_failure_in_children_nephritis_interstitial ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#ReportsWithRenalFunctionabnormal,RenalImpairment> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsOfLevetiracetamBeingTheSinglesuspect-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithARF-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithDRESSsyndrome-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithPositivedechallenge-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithQTprolongation-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRenalfailure-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRenalinsufficiency-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRhabdomyolysisAndStatusepilepticus-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithValproicacid-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithcancer-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithclobazam-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithclonazepam-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithlacosamide-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithlamotrigine-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithoxcarbazepine-adults,RenalFailure> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithphenytoin-adults,RenalFailure> ;
          OpenPVSignal:refers_to_adverse_effect :impairedRenalFunction ;
          OpenPVSignal:refers_to_drug :levetiracetam ;
          OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
          mp:supportedByData :ARF_and_drugs ,
                             :CasesWithAlternativeCausesForARF ,
                             :KeppraProductInfo ,
                             :Levetiracetam_and_impaired_renal_function ,
                             :info_for_another_case ,
                             :info_for_more_cases ,
                             :interstitial_nephritis ,
                             :levetiracetamAndBehaviouralChanges ,
                             :levetiracetamAndTiredness ,
                             :product_info ,
                             :published_cases ,
                             :topiramate_and_nephrolithiasis ,
                             <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#informationAboutFatalreports,non-levetiracetamRelated> ;
          OpenPVSignal:initially_identified_on "01/04/2016" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionqtProlongation
:qtProlongation rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "I45.81" ;
                OpenPVSignal:has_MedDRA_code 10014387 ;
                OpenPVSignal:has_MedDRA_prefered_term "Electrocardiogram QT prolonged" ;
                rdfs:label "qt prolongation" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionrenalAcidosisTubular
:renalAcidosisTubular rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_ICD_code "N25.89" ;
                      OpenPVSignal:has_MedDRA_code 10038535 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Renal tubular acidosis" ;
                      rdfs:label "renal acidosis tubular" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionrenalFailureAcute
:renalFailureAcute rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "N17.9" ;
                   OpenPVSignal:has_MedDRA_code 10069339 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Acute kidney injury" ;
                   rdfs:label "renal failure acute" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionrenalFunctionAbnormal
:renalFunctionAbnormal rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "R94.4" ;
                       OpenPVSignal:has_MedDRA_code 10038451 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Renal function abnormal" ;
                       rdfs:label "renal function abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionrenalInterstitialFibrosis
:renalInterstitialFibrosis rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Adverse_Effect ;
                           OpenPVSignal:has_MedDRA_code 10038475 ;
                           OpenPVSignal:has_MedDRA_prefered_term "Renal interstitial fibrosis" ;
                           rdfs:label "renal interstitial fibrosis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionrenal_failure
:renal_failure rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_MedDRA_code 10038435 ;
               OpenPVSignal:has_MedDRA_prefered_term "Renal failure" ;
               rdfs:label "renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionrenal_impairment
:renal_impairment rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_MedDRA_code 10062237 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Renal impairment" ;
                  rdfs:label "renal impairment" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionrenal_insufficiency
:renal_insufficiency rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10038474 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Renal insufficiency" ;
                     rdfs:label "renal insufficiency" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreport12
:report12 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :info_for_case_with_nephritis_interstitial_2 ;
          OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ,
                                                :renalInterstitialFibrosis ;
          OpenPVSignal:refers_to_concomitant_drug :carbamazepine ,
                                                  :valproicAcid ;
          OpenPVSignal:refers_to_patient :Patient12 ;
          OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
          OpenPVSignal:time_to_onset :time_to_onset_report_with_nephritis_interstitial_2 ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report with nephritis interstitial 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForAzotaemiaAndCreatinineBloodIncreased
:reportsForAzotaemiaAndCreatinineBloodIncreased rdf:type owl:NamedIndividual ,
                                                         OpenPVSignal:Reports_group ;
                                                OpenPVSignal:is_subgroup_of :overallReportsInVigibase ;
                                                OpenPVSignal:refers_to_adverse_effect :Creatinine_blood_increased ,
                                                                                      :azotaemia ;
                                                OpenPVSignal:has_count 1 ;
                                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                rdfs:label "reports for azotaemia and creatinine blood increased" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAcute
:reportsForRenalFailureAcute rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Reports_group ;
                             OpenPVSignal:is_subgroup_of :overallReportsInVigibase ;
                             OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                             OpenPVSignal:has_count 29 ;
                             OpenPVSignal:refers_to_database "WHO Vigibase" ;
                             rdfs:label "reports for renal failure acute" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAndLevetiracetamInAdults
:reportsForRenalFailureAndLevetiracetamInAdults rdf:type owl:NamedIndividual ,
                                                         OpenPVSignal:Reports_group ;
                                                OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                                                OpenPVSignal:refers_to_drug :levetiracetam ;
                                                OpenPVSignal:has_count 90 ;
                                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                rdfs:label "overall reports for renal failure and levetiracetam in adults" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAndLevetiracetamInAdults1
:reportsForRenalFailureAndLevetiracetamInAdults1 rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                 OpenPVSignal:time_to_onset :timeToOnsetForReportsWithRenalFailureInAdults1 ;
                                                 OpenPVSignal:has_count 2 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports for renal failure and levetiracetam in adults onset 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAndLevetiracetamInAdults2
:reportsForRenalFailureAndLevetiracetamInAdults2 rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                 OpenPVSignal:time_to_onset :timeToOnsetForReportsWithRenalFailureInAdults2 ;
                                                 OpenPVSignal:has_count 1 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports for renal failure and levetiracetam in adults onset 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAndLevetiracetamInAdults3
:reportsForRenalFailureAndLevetiracetamInAdults3 rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                 OpenPVSignal:time_to_onset :timeToOnsetForReportsWithRenalFailureInAdults3 ;
                                                 OpenPVSignal:has_count 1 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports for renal failure and levetiracetam in adults onset 3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAndLevetiracetamInAdults4
:reportsForRenalFailureAndLevetiracetamInAdults4 rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                 OpenPVSignal:time_to_onset :timeToOnsetForReportsWithRenalFailureInAdults4 ;
                                                 OpenPVSignal:has_count 1 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports for renal failure and levetiracetam in adults onset 4" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAndLevetiracetamInAdults5
:reportsForRenalFailureAndLevetiracetamInAdults5 rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                 OpenPVSignal:time_to_onset :timeToOnsetForReportsWithRenalFailureInAdults5 ;
                                                 OpenPVSignal:has_count 2 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports for renal failure and levetiracetam in adults onset 5" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAndLevetiracetamInAdults6
:reportsForRenalFailureAndLevetiracetamInAdults6 rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                 OpenPVSignal:time_to_onset :timeToOnsetForReportsWithRenalFailureInAdults6 ;
                                                 OpenPVSignal:has_count 1 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports for renal failure and levetiracetam in adults onset 6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForRenalFailureAndLevetiracetamInAdults7
:reportsForRenalFailureAndLevetiracetamInAdults7 rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                 OpenPVSignal:time_to_onset :timeToOnsetForReportsWithRenalFailureInAdults7 ;
                                                 OpenPVSignal:has_count 1 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports for renal failure and levetiracetam in adults onset 7" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsForadults-interstitialNephritisChildernAndAdults
:reportsForadults-interstitialNephritisChildernAndAdults rdf:type owl:NamedIndividual ,
                                                                  OpenPVSignal:Reports_group ;
                                                         OpenPVSignal:is_subgroup_of :reportsWithInterstitialNephritisInChildrenAndAdults ;
                                                         OpenPVSignal:has_count 13 ;
                                                         OpenPVSignal:has_count_of_men 9 ;
                                                         OpenPVSignal:has_count_of_women 4 ;
                                                         OpenPVSignal:has_max_age 76 ;
                                                         OpenPVSignal:has_median_age 51 ;
                                                         OpenPVSignal:has_min_age 20 ;
                                                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                         rdfs:label "overall reports with interstitial nephritis for adults" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithInterstitialNephritisInChildrenAndAdults
:reportsWithInterstitialNephritisInChildrenAndAdults rdf:type owl:NamedIndividual ,
                                                              OpenPVSignal:Reports_group ;
                                                     OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ;
                                                     OpenPVSignal:refers_to_drug :levetiracetam ;
                                                     OpenPVSignal:has_count 49 ;
                                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                     rdfs:label "overall reports with interstitial nephritis in children and adults" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithLevetiracetamAsASinglesuspect-interstitialNephritisChildernAndAdults
:reportsWithLevetiracetamAsASinglesuspect-interstitialNephritisChildernAndAdults rdf:type owl:NamedIndividual ,
                                                                                          OpenPVSignal:Reports_group ;
                                                                                 OpenPVSignal:is_subgroup_of :reportsForadults-interstitialNephritisChildernAndAdults ;
                                                                                 OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
                                                                                 OpenPVSignal:has_count 6 ;
                                                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                 rdfs:label "reports with interstitial nephritis levetiracetam as a single suspect" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithPositivedechallenge-interstitialNephritisChildernAndAdults
:reportsWithPositivedechallenge-interstitialNephritisChildernAndAdults rdf:type owl:NamedIndividual ,
                                                                                OpenPVSignal:Reports_group ;
                                                                       OpenPVSignal:is_subgroup_of :reportsForadults-interstitialNephritisChildernAndAdults ;
                                                                       OpenPVSignal:has_count 5 ;
                                                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                       OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
                                                                       OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
                                                                       rdfs:label "reports with interstitial nephritis positive dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildren
:reportsWithRenalFailureInChildren rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:is_subgroup_of :overallReportsInVigibase ;
                                   OpenPVSignal:refers_to_drug :levetiracetam ;
                                   OpenPVSignal:has_count 14 ;
                                   OpenPVSignal:has_count_of_men 5 ;
                                   OpenPVSignal:has_count_of_women 7 ;
                                   OpenPVSignal:has_max_age "17.0"^^xsd:float ;
                                   OpenPVSignal:has_median_age "10.5"^^xsd:float ;
                                   OpenPVSignal:has_min_age "0.115"^^xsd:float ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   rdfs:label "overall reports excluding duplicates for children" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenARF
:reportsWithRenalFailureInChildrenARF rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Reports_group ;
                                      OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                      OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                                      OpenPVSignal:has_count 4 ;
                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                      rdfs:label "reports in children ARF" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenClonazepamAsAEDs
:reportsWithRenalFailureInChildrenClonazepamAsAEDs rdf:type owl:NamedIndividual ,
                                                            OpenPVSignal:Reports_group ;
                                                   OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                   OpenPVSignal:refers_to_concomitant_drug :clonazepam ;
                                                   OpenPVSignal:has_count 1 ;
                                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                   rdfs:label "reports in children clonazepam as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenCreatinineIncreased
:reportsWithRenalFailureInChildrenCreatinineIncreased rdf:type owl:NamedIndividual ,
                                                               OpenPVSignal:Reports_group ;
                                                      OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                      OpenPVSignal:refers_to_adverse_effect :bloodCreatinineIncreased ;
                                                      OpenPVSignal:has_count 3 ;
                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                      rdfs:label "reports in children creatinine increased" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenDiazepamAsAEDs
:reportsWithRenalFailureInChildrenDiazepamAsAEDs rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                 OpenPVSignal:refers_to_concomitant_drug :diazepam ;
                                                 OpenPVSignal:has_count 3 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports in children diazepam as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenLacosamideAsAEDs
:reportsWithRenalFailureInChildrenLacosamideAsAEDs rdf:type owl:NamedIndividual ,
                                                            OpenPVSignal:Reports_group ;
                                                   OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                   OpenPVSignal:refers_to_concomitant_drug :lacosamide ;
                                                   OpenPVSignal:has_count 4 ;
                                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                   rdfs:label "reports in children lacosamide as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenLamotrigineAsAEDs
:reportsWithRenalFailureInChildrenLamotrigineAsAEDs rdf:type owl:NamedIndividual ,
                                                             OpenPVSignal:Reports_group ;
                                                    OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                    OpenPVSignal:refers_to_concomitant_drug :lamotrigine ;
                                                    OpenPVSignal:has_count 2 ;
                                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                    rdfs:label "reports in children lamotrigine as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenLevetiracetamAsTheSingleSuspect
:reportsWithRenalFailureInChildrenLevetiracetamAsTheSingleSuspect rdf:type owl:NamedIndividual ,
                                                                           OpenPVSignal:Reports_group ;
                                                                  OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                                  OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
                                                                  OpenPVSignal:has_count 6 ;
                                                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                  rdfs:label "reports in children levetiracetam as the single suspect" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenPhenobarbitalAsAEDs
:reportsWithRenalFailureInChildrenPhenobarbitalAsAEDs rdf:type owl:NamedIndividual ,
                                                               OpenPVSignal:Reports_group ;
                                                      OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                      OpenPVSignal:refers_to_concomitant_drug :phenobarbital ;
                                                      OpenPVSignal:has_count 3 ;
                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                      rdfs:label "reports in children phenobarbital as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenPhenytoinAsAEDs
:reportsWithRenalFailureInChildrenPhenytoinAsAEDs rdf:type owl:NamedIndividual ,
                                                           OpenPVSignal:Reports_group ;
                                                  OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                  OpenPVSignal:refers_to_concomitant_drug :phenytoin ;
                                                  OpenPVSignal:has_count 2 ;
                                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                  rdfs:label "reports in children phenytoin as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenRenalFailure
:reportsWithRenalFailureInChildrenRenalFailure rdf:type owl:NamedIndividual ,
                                                        OpenPVSignal:Reports_group ;
                                               OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                               OpenPVSignal:refers_to_adverse_effect :renal_failure ;
                                               OpenPVSignal:has_count 6 ;
                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                               rdfs:label "reports in children renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenThiopentalAsAEDs
:reportsWithRenalFailureInChildrenThiopentalAsAEDs rdf:type owl:NamedIndividual ,
                                                            OpenPVSignal:Reports_group ;
                                                   OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                   OpenPVSignal:refers_to_concomitant_drug :thiopental ;
                                                   OpenPVSignal:has_count 2 ;
                                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                   rdfs:label "reports in children thiopental as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenTopiramateAsAEDs
:reportsWithRenalFailureInChildrenTopiramateAsAEDs rdf:type owl:NamedIndividual ,
                                                            OpenPVSignal:Reports_group ;
                                                   OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                   OpenPVSignal:refers_to_concomitant_drug :topiramate ;
                                                   OpenPVSignal:has_count 1 ;
                                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                   rdfs:label "reports in children topiramate as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenValproicAcidAsAEDs
:reportsWithRenalFailureInChildrenValproicAcidAsAEDs rdf:type owl:NamedIndividual ,
                                                              OpenPVSignal:Reports_group ;
                                                     OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                     OpenPVSignal:refers_to_concomitant_drug :valproicAcid ;
                                                     OpenPVSignal:has_count 3 ;
                                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                     rdfs:label "reports in children valproic acid as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInChildrenrenalImpairment
:reportsWithRenalFailureInChildrenrenalImpairment rdf:type owl:NamedIndividual ,
                                                           OpenPVSignal:Reports_group ;
                                                  OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                  OpenPVSignal:refers_to_adverse_effect :impairedRenalFunction ;
                                                  OpenPVSignal:has_count 1 ;
                                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                  rdfs:label "reports in children renal impairment" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithRenalFailureInchildren-clobazamAsAEDs
:reportsWithRenalFailureInchildren-clobazamAsAEDs rdf:type owl:NamedIndividual ,
                                                           OpenPVSignal:Reports_group ;
                                                  OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                                  OpenPVSignal:refers_to_concomitant_drug :clobazam ;
                                                  OpenPVSignal:has_count 1 ;
                                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                  rdfs:label "reports in children clobazam as AEDs" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithTimeToOnsetinfo-interstitialNephritisChildernAndAdults
:reportsWithTimeToOnsetinfo-interstitialNephritisChildernAndAdults rdf:type owl:NamedIndividual ,
                                                                            OpenPVSignal:Reports_group ;
                                                                   OpenPVSignal:is_subgroup_of :reportsForadults-interstitialNephritisChildernAndAdults ;
                                                                   OpenPVSignal:time_to_onset :timeToOnsetForReportsWithInterstitialNephritisInChildrenAndAdults ;
                                                                   OpenPVSignal:has_count 5 ;
                                                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                   rdfs:label "reports with interstitial nephritis time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithValproicacid-interstitialNephritisChildernAndAdults
:reportsWithValproicacid-interstitialNephritisChildernAndAdults rdf:type owl:NamedIndividual ,
                                                                         OpenPVSignal:Reports_group ;
                                                                OpenPVSignal:is_subgroup_of :reportsForadults-interstitialNephritisChildernAndAdults ;
                                                                OpenPVSignal:refers_to_concomitant_drug :valproicAcid ;
                                                                OpenPVSignal:has_count 5 ;
                                                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                rdfs:label "reports with interstitial nephritis valproic acid" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithcarbamazepine-interstitialNephritisChildernAndAdults
:reportsWithcarbamazepine-interstitialNephritisChildernAndAdults rdf:type owl:NamedIndividual ,
                                                                          OpenPVSignal:Reports_group ;
                                                                 OpenPVSignal:is_subgroup_of :reportsForadults-interstitialNephritisChildernAndAdults ;
                                                                 OpenPVSignal:refers_to_concomitant_drug :carbamazepine ;
                                                                 OpenPVSignal:has_count 2 ;
                                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                 rdfs:label "reports with interstitial nephritis carbamazepine" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithclobazam-interstitialNephritisChildernAndAdults
:reportsWithclobazam-interstitialNephritisChildernAndAdults rdf:type owl:NamedIndividual ,
                                                                     OpenPVSignal:Reports_group ;
                                                            OpenPVSignal:is_subgroup_of :reportsForadults-interstitialNephritisChildernAndAdults ;
                                                            OpenPVSignal:refers_to_concomitant_drug :clobazam ;
                                                            OpenPVSignal:has_count 1 ;
                                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                            rdfs:label "reports with interstitial nephritis clobazam" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreportsWithtopiramate-interstitialNephritisChildernAndAdults
:reportsWithtopiramate-interstitialNephritisChildernAndAdults rdf:type owl:NamedIndividual ,
                                                                       OpenPVSignal:Reports_group ;
                                                              OpenPVSignal:is_subgroup_of :reportsForadults-interstitialNephritisChildernAndAdults ;
                                                              OpenPVSignal:refers_to_concomitant_drug :topiramate ;
                                                              OpenPVSignal:has_count 1 ;
                                                              OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                              rdfs:label "reports with interstitial nephritis topiramate" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreports_for_renal_failure_and_levetiracetam_in_adults_onset_0
:reports_for_renal_failure_and_levetiracetam_in_adults_onset_0 rdf:type owl:NamedIndividual ,
                                                                        OpenPVSignal:Reports_group ;
                                                               OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                               OpenPVSignal:time_to_onset :time_to_onset_for_reports_with_renal_failure_in_adults_0 ;
                                                               OpenPVSignal:has_count 1 ;
                                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                               rdfs:label "reports for renal failure and levetiracetam in adults onset 0" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreports_in_adults_status_epilepticus
:reports_in_adults_status_epilepticus rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Reports_group ;
                                      OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                      OpenPVSignal:refers_to_adverse_effect :statusEpilepticus ;
                                      OpenPVSignal:has_count 1 ;
                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                      rdfs:label "reports in adults status epilepticus" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreports_in_children_case_reports
:reports_in_children_case_reports rdf:type owl:NamedIndividual ,
                                           OpenPVSignal:Reports_group ;
                                  OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                  OpenPVSignal:has_count 5 ;
                                  OpenPVSignal:has_reporter_type "study" ;
                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                  rdfs:label "reports in children case reports" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreports_in_children_dose_info
:reports_in_children_dose_info rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Reports_group ;
                               OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                               OpenPVSignal:refers_to_dosage :dose_info ;
                               OpenPVSignal:has_count 9 ;
                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                               rdfs:label "reports in children dose info" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreports_in_children_hepatic_disorders
:reports_in_children_hepatic_disorders rdf:type owl:NamedIndividual ,
                                                OpenPVSignal:Reports_group ;
                                       OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildren ;
                                       OpenPVSignal:refers_to_adverse_effect :hepatic_disorders ;
                                       OpenPVSignal:has_count 5 ;
                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                       rdfs:label "reports in children hepatic disorders" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionreports_with_renal_failure_in_children_nephritis_interstitial
:reports_with_renal_failure_in_children_nephritis_interstitial rdf:type owl:NamedIndividual ,
                                                                        OpenPVSignal:Reports_group ;
                                                               OpenPVSignal:is_subgroup_of :reportsWithRenalFailureInChildrenARF ;
                                                               OpenPVSignal:refers_to_adverse_effect :interstitialNephritis ;
                                                               OpenPVSignal:has_count 1 ;
                                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                               rdfs:label "reports in children nephritis interstitial" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionrhabdomyolysis
:rhabdomyolysis rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "M62.82" ;
                OpenPVSignal:has_MedDRA_code 10039020 ;
                OpenPVSignal:has_MedDRA_prefered_term "Rhabdomyolysis" ;
                rdfs:label "rhabdomyolysis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionseizure
:seizure rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Indication ;
         OpenPVSignal:has_MedDRA_code 10039906 ;
         OpenPVSignal:has_MedDRA_prefered_term "Seizure" ;
         rdfs:label "seizure" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionsimvastatin
:simvastatin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C10AA01Â " ;
             rdfs:label "simvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionsomnolence
:somnolence rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "R40.0" ;
            OpenPVSignal:has_MedDRA_code 10041349 ;
            OpenPVSignal:has_MedDRA_prefered_term "Somnolence" ;
            rdfs:label "somnolence" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionstatusEpilepticus
:statusEpilepticus rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "G40.901" ;
                   OpenPVSignal:has_MedDRA_code 10041962 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Status epilepticus" ;
                   rdfs:label "status epilepticus" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionsulphonamides
:sulphonamides rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "J01EC" ;
               rdfs:label "sulphonamides" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontemozolomide
:temozolomide rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "L01AX03" ;
              rdfs:label "temozolomide" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionthiopental
:thiopental rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N01AF03" ,
                                      "N05CA19" ,
                                      "N05CB01" ;
            rdfs:label "thiopental" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetForReportsWithInterstitialNephritisInChildrenAndAdults
:timeToOnsetForReportsWithInterstitialNephritisInChildrenAndAdults rdf:type owl:NamedIndividual ,
                                                                            time:DurationDescription ;
                                                                   OpenPVSignal:has_content "Time to onset could be assessed in five reports and ranged from 1 to 12 months." ;
                                                                   rdfs:label "time to onset for reports with Interstitial nephritis in children and adults " .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetForReportsWithRenalFailureInAdults1
:timeToOnsetForReportsWithRenalFailureInAdults1 rdf:type owl:NamedIndividual ,
                                                         time:DurationDescription ;
                                                OpenPVSignal:has_content "Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days." ;
                                                time:nominalPosition "days" ;
                                                time:numericPosition 1 ;
                                                rdfs:label "time to onset for reports with renal failure in adults 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetForReportsWithRenalFailureInAdults2
:timeToOnsetForReportsWithRenalFailureInAdults2 rdf:type owl:NamedIndividual ,
                                                         time:DurationDescription ;
                                                OpenPVSignal:has_content "Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days." ;
                                                time:nominalPosition "days" ;
                                                time:numericPosition 4 ;
                                                rdfs:label "time to onset for reports with renal failure in adults 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetForReportsWithRenalFailureInAdults3
:timeToOnsetForReportsWithRenalFailureInAdults3 rdf:type owl:NamedIndividual ,
                                                         time:DurationDescription ;
                                                OpenPVSignal:has_content "Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days." ;
                                                time:nominalPosition "days" ;
                                                time:numericPosition 20 ;
                                                rdfs:label "time to onset for reports with renal failure in adults 3" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetForReportsWithRenalFailureInAdults4
:timeToOnsetForReportsWithRenalFailureInAdults4 rdf:type owl:NamedIndividual ,
                                                         time:DurationDescription ;
                                                OpenPVSignal:has_content "Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days." ;
                                                time:nominalPosition "days" ;
                                                time:numericPosition 30 ;
                                                rdfs:label "time to onset for reports with renal failure in adults 4" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetForReportsWithRenalFailureInAdults5
:timeToOnsetForReportsWithRenalFailureInAdults5 rdf:type owl:NamedIndividual ,
                                                         time:DurationDescription ;
                                                OpenPVSignal:has_content "Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days." ;
                                                time:nominalPosition "days" ;
                                                time:numericPosition 90 ;
                                                rdfs:label "time to onset for reports with renal failure in adults 5" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetForReportsWithRenalFailureInAdults6
:timeToOnsetForReportsWithRenalFailureInAdults6 rdf:type owl:NamedIndividual ,
                                                         time:DurationDescription ;
                                                OpenPVSignal:has_content "Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days." ;
                                                time:nominalPosition "months" ;
                                                time:numericPosition 4 ;
                                                rdfs:label "time to onset for reports with renal failure in adults 6" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetForReportsWithRenalFailureInAdults7
:timeToOnsetForReportsWithRenalFailureInAdults7 rdf:type owl:NamedIndividual ,
                                                         time:DurationDescription ;
                                                OpenPVSignal:has_content "Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days." ;
                                                time:nominalPosition "months" ;
                                                time:numericPosition 15 ;
                                                rdfs:label "time to onset for reports with renal failure in adults 7" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetReport11
:timeToOnsetReport11 rdf:type owl:NamedIndividual ,
                              time:DurationDescription ;
                     time:nominalPosition "months" ;
                     time:numericPosition 5 ;
                     rdfs:label "time to onset report with nephritis interstitial 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontimeToOnsetReport12
:timeToOnsetReport12 rdf:type owl:NamedIndividual ,
                              time:DurationDescription ;
                     time:nominalPosition "months" ;
                     time:numericPosition 4 ;
                     rdfs:label "time to onset report 12" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontime_to_onset_for_reports_with_renal_failure_in_adults_0
:time_to_onset_for_reports_with_renal_failure_in_adults_0 rdf:type owl:NamedIndividual ,
                                                                   time:DurationDescription ;
                                                          OpenPVSignal:has_content "Time to onset of the renal failure could be determined in ten cases specified to: the same day, 1, 1, 4, 20, 30, 90 (n=2) days, and approximately 4 and 15 months after levetiracetam start, with a median of 26.5 days." ;
                                                          time:nominalPosition "days" ;
                                                          time:numericPosition 0 ;
                                                          rdfs:label "time to onset for reports with renal failure in adults 0" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontime_to_onset_report_with_nephritis_interstitial_2
:time_to_onset_report_with_nephritis_interstitial_2 rdf:type owl:NamedIndividual ,
                                                             time:DurationDescription ;
                                                    time:nominalPosition "months" ;
                                                    time:numericPosition 4 ;
                                                    rdfs:label "time to onset report with nephritis interstitial 2" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontiredness
:tiredness rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R53.83" ;
           OpenPVSignal:has_MedDRA_code 10043890 ;
           OpenPVSignal:has_MedDRA_prefered_term "Tiredness" ;
           rdfs:label "tiredness" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontopiramate
:topiramate rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AX11" ;
            rdfs:label "topiramate" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontopiramate_and_nephrolithiasis
:topiramate_and_nephrolithiasis rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Warning_Information ;
                                OpenPVSignal:refers_to_adverse_effect :nephrolithiasis ;
                                OpenPVSignal:refers_to_drug :topiramate ;
                                OpenPVSignal:has_content "Topiramate is an example of a medicine inducing nephrolithiasis.2" ;
                                rdfs:label "topiramate and nephrolithiasis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontramadol
:tramadol rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N02AX02" ,
                                    "N02AX52" ;
          rdfs:label "tramadol" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functiontremor
:tremor rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R25.1" ;
        OpenPVSignal:has_MedDRA_code 10044565 ;
        OpenPVSignal:has_MedDRA_prefered_term "Tremor" ;
        rdfs:label "tremor" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionurinary_tract_stenosis
:urinary_tract_stenosis rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "N35" ;
                        OpenPVSignal:has_MedDRA_code 10041997 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Stenosis trigone urinary bladder" ;
                        rdfs:label "urinary tract stenosis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionusage_for_report_with_nephritis_interstitial_1
:usage_for_report_with_nephritis_interstitial_1 rdf:type owl:NamedIndividual ,
                                                         OpenPVSignal:Drug_Usage ;
                                                OpenPVSignal:refers_to_dosage :dose_for_report_with_nephritis_interstitial_1 ;
                                                OpenPVSignal:refers_to_drug :levetiracetam ;
                                                rdfs:label "usage for report with nephritis interstitial 1" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionvalproicAcid
:valproicAcid rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "N03AG01" ;
              rdfs:label "valproic acid" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionvancomycin
:vancomycin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "J01XA01" ;
            rdfs:label "vancomycin" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_functionvomiting
:vomiting rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R11.10" ;
          OpenPVSignal:has_MedDRA_code 10047700 ;
          OpenPVSignal:has_MedDRA_prefered_term "Vomiting" ;
          rdfs:label "vomiting" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#ReportsWithRenalFunctionabnormal,RenalImpairment
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#ReportsWithRenalFunctionabnormal,RenalImpairment> rdf:type owl:NamedIndividual ,
                                                                                                                                              OpenPVSignal:Reports_group ;
                                                                                                                                     OpenPVSignal:is_subgroup_of :overallReportsInVigibase ;
                                                                                                                                     OpenPVSignal:refers_to_adverse_effect :renalFunctionAbnormal ,
                                                                                                                                                                           :renal_impairment ;
                                                                                                                                     OpenPVSignal:has_count 5 ;
                                                                                                                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                     rdfs:label "reports with renal function abnormal, renal impairment" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#informationAboutFatalreports,non-levetiracetamRelated
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#informationAboutFatalreports,non-levetiracetamRelated> rdf:type owl:NamedIndividual ,
                                                                                                                                                   obo:OAE_0001125 ,
                                                                                                                                                   OpenPVSignal:Case_Report_Information ;
                                                                                                                                          OpenPVSignal:has_content """A 9-year-old male experienced status epilepticus with metabolic acidosis and developed rhabdomyolysis and hepatorenal failure.6
A 3-year-old female where the focus was on status epilepticus and the sudden interruption of lacosamide treatment.7""" ;
                                                                                                                                          rdfs:label "information about fatal reports, non-levetiracetam related" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsOfLevetiracetamBeingTheSinglesuspect-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsOfLevetiracetamBeingTheSinglesuspect-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                                             OpenPVSignal:Reports_group ;
                                                                                                                                                    OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                                                    OpenPVSignal:refers_to_primary_suspect_drug :levetiracetam ;
                                                                                                                                                    OpenPVSignal:has_count 5 ;
                                                                                                                                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                    rdfs:label "reports in adults levetiracetam being the single suspect" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithARF-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithARF-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                OpenPVSignal:Reports_group ;
                                                                                                                       OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                       OpenPVSignal:refers_to_adverse_effect :acuteRenalFailure ;
                                                                                                                       OpenPVSignal:has_count 10 ;
                                                                                                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                       rdfs:label "reports in adults ARF" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithDRESSsyndrome-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithDRESSsyndrome-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                          OpenPVSignal:Reports_group ;
                                                                                                                                 OpenPVSignal:is_subgroup_of :reportsForRenalFailureAndLevetiracetamInAdults ;
                                                                                                                                 OpenPVSignal:refers_to_adverse_effect :dressSyndrome ;
                                                                                                                                 OpenPVSignal:has_count 2 ;
                                                                                                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                 rdfs:label "reports in adults DRESS syndrome" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithPositivedechallenge-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithPositivedechallenge-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                                OpenPVSignal:Reports_group ;
                                                                                                                                       OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                                       OpenPVSignal:has_count 8 ;
                                                                                                                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                       OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
                                                                                                                                       OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
                                                                                                                                       rdfs:label "reports in adults positive dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithQTprolongation-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithQTprolongation-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                           OpenPVSignal:Reports_group ;
                                                                                                                                  OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                                  OpenPVSignal:refers_to_adverse_effect :qtProlongation ;
                                                                                                                                  OpenPVSignal:has_count 2 ;
                                                                                                                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                  rdfs:label "reports in adults QT prolongation" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRenalfailure-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRenalfailure-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                         OpenPVSignal:Reports_group ;
                                                                                                                                OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                                OpenPVSignal:refers_to_adverse_effect :renal_failure ;
                                                                                                                                OpenPVSignal:has_count 1 ;
                                                                                                                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                rdfs:label "reports in adults renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRenalinsufficiency-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRenalinsufficiency-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                               OpenPVSignal:Reports_group ;
                                                                                                                                      OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                                      OpenPVSignal:refers_to_adverse_effect :renal_insufficiency ;
                                                                                                                                      OpenPVSignal:has_count 1 ;
                                                                                                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                      rdfs:label "reports in adults renal insufficiency" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRhabdomyolysisAndStatusepilepticus-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithRhabdomyolysisAndStatusepilepticus-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                                               OpenPVSignal:Reports_group ;
                                                                                                                                                      OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                                                      OpenPVSignal:refers_to_adverse_effect :rhabdomyolysis ;
                                                                                                                                                      OpenPVSignal:has_count 1 ;
                                                                                                                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                      rdfs:label "reports in adults rhabdomyolysis" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                                        OpenPVSignal:Reports_group ;
                                                                                                                                               OpenPVSignal:is_subgroup_of :reportsForRenalFailureAndLevetiracetamInAdults ;
                                                                                                                                               OpenPVSignal:refers_to_drug :levetiracetam ;
                                                                                                                                               OpenPVSignal:has_count 12 ;
                                                                                                                                               OpenPVSignal:has_count_of_men 7 ;
                                                                                                                                               OpenPVSignal:has_count_of_women 5 ;
                                                                                                                                               OpenPVSignal:has_max_age "73.0"^^xsd:float ;
                                                                                                                                               OpenPVSignal:has_median_age "45.0"^^xsd:float ;
                                                                                                                                               OpenPVSignal:has_min_age "21.0"^^xsd:float ;
                                                                                                                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                               rdfs:label "overall reports with score in vigiGrade more than 0.8 for adults" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithValproicacid-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithValproicacid-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                         OpenPVSignal:Reports_group ;
                                                                                                                                OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                                OpenPVSignal:refers_to_concomitant_drug :valproicAcid ;
                                                                                                                                OpenPVSignal:has_count 2 ;
                                                                                                                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                rdfs:label "reports in adults valproic acid" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithcancer-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithcancer-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                   OpenPVSignal:Reports_group ;
                                                                                                                          OpenPVSignal:is_subgroup_of :reportsForRenalFailureAndLevetiracetamInAdults ;
                                                                                                                          OpenPVSignal:refers_to_adverse_effect :cancer ;
                                                                                                                          OpenPVSignal:has_count 2 ;
                                                                                                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                          rdfs:label "reports in adults cancer" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithclobazam-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithclobazam-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                     OpenPVSignal:Reports_group ;
                                                                                                                            OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                            OpenPVSignal:refers_to_concomitant_drug :clobazam ;
                                                                                                                            OpenPVSignal:has_count 1 ;
                                                                                                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                            rdfs:label "reports in adults clobazam" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithclonazepam-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithclonazepam-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                       OpenPVSignal:Reports_group ;
                                                                                                                              OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                              OpenPVSignal:refers_to_concomitant_drug :clonazepam ;
                                                                                                                              OpenPVSignal:has_count 1 ;
                                                                                                                              OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                              rdfs:label "reports in adults clonazepam" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithlacosamide-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithlacosamide-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                       OpenPVSignal:Reports_group ;
                                                                                                                              OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                              OpenPVSignal:refers_to_concomitant_drug :lacosamide ;
                                                                                                                              OpenPVSignal:has_count 1 ;
                                                                                                                              OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                              rdfs:label "reports in adults lacosamide" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithlamotrigine-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithlamotrigine-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                        OpenPVSignal:Reports_group ;
                                                                                                                               OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                               OpenPVSignal:refers_to_concomitant_drug :lamotrigine ;
                                                                                                                               OpenPVSignal:has_count 3 ;
                                                                                                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                               rdfs:label "reports in adults lamotrigine" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithoxcarbazepine-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithoxcarbazepine-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                          OpenPVSignal:Reports_group ;
                                                                                                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                                 OpenPVSignal:refers_to_concomitant_drug :oxcarbazepine ;
                                                                                                                                 OpenPVSignal:has_count 1 ;
                                                                                                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                 rdfs:label "reports in adults oxcarbazepine" .


###  http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithphenytoin-adults,RenalFailure
<http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithphenytoin-adults,RenalFailure> rdf:type owl:NamedIndividual ,
                                                                                                                                      OpenPVSignal:Reports_group ;
                                                                                                                             OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2016_2_levetiracetam_impaired_renal_function#reportsWithScoreInvigiGradeMoreThan0.8-adults,RenalFailure> ;
                                                                                                                             OpenPVSignal:refers_to_concomitant_drug :phenytoin ;
                                                                                                                             OpenPVSignal:has_count 2 ;
                                                                                                                             OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                             rdfs:label "reports in adults phenytoin" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
